Next Article in Journal
Comprehensive Evaluation of 24 Red Raspberry Varieties in Northeast China Based on Nutrition and Taste
Next Article in Special Issue
The Effect of Spice Powders on Bioactive Compounds, Antioxidant Activity, Phenolic Components, Fatty Acids, Mineral Contents and Sensory Properties of “Keşkek”, Which Is a Traditional Food
Previous Article in Journal
Effects of Five Different Lactic Acid Bacteria on Bioactive Components and Volatile Compounds of Oat
Previous Article in Special Issue
Performance of Thermoplastic Extrusion, Germination, Fermentation, and Hydrolysis Techniques on Phenolic Compounds in Cereals and Pseudocereals
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Cereals as a Source of Bioactive Compounds with Anti-Hypertensive Activity and Their Intake in Times of COVID-19

by
Abigail García-Castro
1,
Alma Delia Román-Gutiérrez
1,*,
Araceli Castañeda-Ovando
1,
Raquel Cariño-Cortés
2,
Otilio Arturo Acevedo-Sandoval
1,
Patricia López-Perea
3 and
Fabiola Araceli Guzmán-Ortiz
4,*
1
Área Académica de Química, Universidad Autónoma del Estado de Hidalgo, Carretera Pachuca–Tulancingo, Km 4.5 s/n, Mineral de la Reforma, Hidalgo 42184, Mexico
2
Área Académica de Medicina, Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Elíseo Ramírez Ulloa, 400, Doctores, Pachuca de Soto 42090, Mexico
3
Área de Ingeniería Agroindustrial, Universidad Politécnica Francisco I. Madero, Francisco I. Madero, Hidalgo 42660, Mexico
4
CONACYT, Universidad Autónoma del Estado de Hidalgo, Carretera Pachuca-Tulancingo Km 4.5 s/n, Mineral de la Reforma, Hidalgo 42184, Mexico
*
Authors to whom correspondence should be addressed.
Foods 2022, 11(20), 3231; https://doi.org/10.3390/foods11203231
Submission received: 17 September 2022 / Revised: 8 October 2022 / Accepted: 11 October 2022 / Published: 16 October 2022

Abstract

:
Cereals have phytochemical compounds that can diminish the incidence of chronic diseases such as hypertension. The angiotensin-converting enzyme 2 (ACE2) participates in the modulation of blood pressure and is the principal receptor of the virus SARS-CoV-2. The inhibitors of the angiotensin-converting enzyme (ACE) and the block receptors of angiotensin II regulate the expression of ACE2; thus, they could be useful in the treatment of patients infected with SARS-CoV-2. The inferior peptides from 1 to 3 kDa and the hydrophobic amino acids are the best candidates to inhibit ACE, and these compounds are present in rice, corn, wheat, oats, sorghum, and barley. In addition, the vitamins C and E, phenolic acids, and flavonoids present in cereals show a reduction in the oxidative stress involved in the pathogenesis of hypertension. The influence of ACE on hypertension and COVID-19 has turned into a primary point of control and treatment from the nutritional perspective. The objective of this work was to describe the inhibitory effect of the angiotensin-converting enzyme that the bioactive compounds present in cereals possess in order to lower blood pressure and how their consumption could be associated with reducing the virulence of COVID-19.

Graphical Abstract

1. Introduction

Cereals constitute an important part of the daily diet due to their high content of proteins, dietary fiber, and bioactive compounds with antioxidant and anti-inflammatory activities, which help prevent diseases related to metabolic syndromes such as obesity, cardiovascular diseases, and type 2 diabetes [1,2]. Wheat, oats, barley, and rice have been reported to have antihypertensive and antioxidant activities due to their content of phytochemical compounds that participate in hormonal regulation mechanisms that help lower blood pressure and other non-transmissible diseases [3,4,5,6].
Peptides derived from food have a high potential regarding the development of nutraceuticals and functional foods due to their specificity and molecular weight [7]. According to Cavazos and Mejia [8], the anti-hypertensive activity of the bioactive peptides presents in cereals with hypotensive effects contribute to preventing cardiovascular diseases. Likewise, it has been discovered that the hydrolyzed proteins and phenolic compounds promote the regulation of oxidative stress and decrease the appearance of associated chronic diseases [9,10].
Hypertension has been one of the most important comorbidities that contribute to the development of cardiovascular diseases. Recently, during the pandemic caused by the coronavirus SARS-CoV-2, the most common comorbidities in patients with COVID-19 have been reported, of which hypertension (30%), diabetes (19%), and coronary diseases (8%) stand out [11]. Some recent findings showed an important role of the Renin–angiotensin–aldosterone system (RAAS) in hypertensive patients diagnosed with COVID-19. This is because SARS-CoV-2 utilizes the angiotensin-converting enzyme 2 (ACE2) to unite in the surface of epithelial cells. Thus, controlling the production of ACE2 can mediate the entry of SARS-CoV-2 in the cells [12].
Some hypertensive drugs, such as the blocking receptors of angiotensin II (BRA), can modify the expression of ACE2 [13,14], which could decrease the virulence of SARS-CoV-2. The objective of this review is to describe the anti-hypertensive activity present in some bioactive compounds in cereals, wherein activities such as the inhibition of ACE, its participation in oxidative stress, and its consumption could be associated with the prevention of COVID-19. Furthermore, some angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARBs) used in the treatment of hypertensive patients diagnosed with COVID-19 are described.

2. Physiopathology of Hypertension

High blood pressure, also known as hypertension, is a public health problem suffered by around 1.3 million adults worldwide. This condition occurs when an elevation in the systolic and diastolic pressure occurs above 140/90 mmHg, respectively [15]. Studies relate the hyperactivation of the renin angiotensin system [16,17], oxidative stress [18], and chronic inflammation [19] as the principal causes in the development of hypertension. Other factors related to hypertension include biochemical processes, such as the increase in the sympathetic activity of the nervous system, the inadequate intake of calcium and potassium, and alterations in the secretion of renin, a hormone related to the elevation in the activity of the angiotensin renin system [20]. In addition, the increased activity of ACE causes a high production of the hormone angiotensin II, as well as deficiencies in vasodilators including vascular inflammatory factors, which promote an alteration in cellular ion channels [20].
The RAAS is the principal mechanism that affects the regulation of blood pressure. An increase in the renin hormone caused by an increment in the intake of sodium provokes the stimulation of the production of the physiologically inactive hormone called angiotensin-I (Ang-I), which is converted into angiotensin II (Ang-II) due to the angiotensin-converter enzyme (ACE-I). Ang II is a vasoconstrictor that stimulates the production of aldosterone, which causes an increase in blood pressure through the retention of sodium and water. This induces the activation of the epithelial sodium channel stimulating the reabsorption of the Na+ in the cortical duct (Figure 1) [17,21].
Although the potential of antihypertensive drugs to lower blood pressure in individuals with hypertension has been shown, lifestyle habits, such as regular exercise and healthy eating, have also been reported to have a positive effect on blood pressure control [22]. Some mechanisms used by the bioactive compounds present in food, mainly polyphenolic compounds to reduce hypertension, include the reduction in the levels of the vasoconstrictor molecule I and the increase in the antioxidant glutathione [23], which improve the production of vasodilator factors such as oxide nitric [24] and inhibit the expression of proangiogenic factors such as vascular endothelial growth factor [25].
Therefore, a better understanding of the hormonal mechanisms that control high blood pressure could clarify the causes and effects that a drug treatment combined with a diet rich in cereals could have on the control of hypertension, effectively reducing inflammation and oxidative stress and strengthening the immune system during the COVID-19 crisis.

3. Hypertension: Main Comorbidity in Patients with COVID-19

COVID-19, caused by the SARS-CoV-2 virus, is an infectious disease that has provoked a sanitary crisis worldwide. The pathogenesis of the SARS-CoV-2 virus starts by means of the union of the protein of the viral peak with the target receptor of ACE2, which facilitates the internalization of the virus within the host cells. It was reported that SARS-Cov-2 is a virus whose tropism is based on the use of ACE2 to unite the epithelial cells of the organism [26,27]. The ACE balances blood pressure and converts angiotensin I into angiotensin II with a vasoconstrictive function and at the same time facilitates the degradation of a vasodilator termed bradykinin [28]. The control over these hormonal processes balances the health of hypertensive patients. However, a combination of other diseases makes it difficult to control and, in many cases, can worsen the evolution of each illness. Therefore, the initial reports suggest that hypertension, diabetes, and cardiovascular diseases are the most frequent comorbidities in COVID-19 [29].
The ACE2 can change the balance of the RAAS by means of the conversion of Ang II to Ang (1-7). Therefore, hypertension and COVID-19 have developed into a recent concern over the susceptibility of patients with hypertension to develop COVID-19, as it increases the severity of the illness and the use of ACEi and ARBs [30].
The inhibitors utilized in the treatment of hypertension increase the expression of ACE2 on the cellular surface and can increase the expression of the intestinal messenger ribonucleic acid (ARNm) of ACE2. Although there are few data concerning the effects of these drugs regarding the expression of the ARNm of ACE2 in the pulmonary epithelial cells, there exists the concern that the patients who take these treatments can encourage the contraction of the virus [31].
An optimum immune response is the key to maintaining control over infectious and non-infectious diseases. An increase in the intake of whole cereals rich in fiber and polysaccharides is associated with a reduction in PCR-hs (a marker used to predict cardiovascular events in patients with atherosclerosis via Polymerase Chain Reaction) [32]; decreased interleukin-6 (IL-6) [33], which is produced in response to infections and tissue damage; and tumor necrosis factor alpha (TNF-α), an inflammatory cytokine produced by macrophages/monocytes during acute inflammation [2]; therefore, cereals reduce the risk of suffering illnesses predicted by inflammation such as cardiovascular diseases [34] and diabetes type II [35].
Since blood pressure is difficult to control, the most widely used resources involve identifying drug targets to effectively control and manage blood pressure in hypertensive patients.

4. Anti-Hypertensive Drugs and Their Use in the Treatment of COVID-19

The use of ACEi and ARBs have been associated with a decrease in the mortality of a hospital population diagnosed with COVID-19 and with a reduction in the hospital in-patient stay observed with a greater effect in patients with hypertension [36].
However, it has been shown that ACEi and ARBs could facilitate the entry of the virus into the host cell and increase the chances of infection or its severity, although there are no conclusive studies [37]. In a study of 187 patients with COVID-19 (the mean age was 58.5 years), it was observed that the mortality of those treated with ACEi/ARBs did not show a significant difference with those who were not treated with ACEi/ARBs [38].
Martínez-del Río et al. [39] reported that the use of ACEi and antagonists of the angiotensin receptor 2 (ARA2) in elderly patients does not increase the risk of death or the use of assisted ventilation, but the use of these drugs overexpress ACE2 and increases the risk of infection. This enzyme acts by inhibiting angiotensin 2 and increasing the production of angiotensin 1–7 with anti-inflammatory and vasodilator effects [40], which have been found in greater levels in persons that have survived respiratory stress than in persons who have perished [41].
Braude et al. [36] reported the influence of ACEi and ARBs on mortality in 1371 patients with a mean age of 74 years diagnosed with COVID-19. The results showed a significant reduction in hospital stay. This was because ACEi decreases the production of ACE2, as it blocks the conversion of ACE1 to ACE2, and the ARBs block the receptor of angiotensin II type I impeding the actions of ACE2 concerning pulmonary vasoconstriction and endothelial permeability, thereby diminishing the injury at the pulmonary level. Therefore, the use of ACEi could decrease the progression and mortality of patients with COVID-19.
One strategy to treat infection with COVID-19 is to inhibit the entry of SARS-CoV-2 in the host cell through the receptors of ACE2 [42]. Consequently, the positive regulation of ACE2 in infected patients with SARS-CoV-2 could be clinically useful due to the vascular protection provided by the activity of angiotensin 1–7, thereby diminishing the effects of angiotensin II on vasoconstriction and the retention of sodium [43].
Bioactive compounds are valuable for drug development and adjunctive therapies for the related infection. These compounds can act as preventive agents or as treatment accelerators. Flavanones, flavones, and saponins are some natural ACE2 inhibitors [44,45]. Saponins can inhibit the binding of COVID-19 protein S to ACE2 receptors [46] (Figure 2).
The peptide inhibitors that are used in the treatment of diverse diseases could also be potential agents against COVID-19. The bioactive peptides with unique sequences of amino acids can mitigate the inhibition of the transmembrane proteases and serine type II (TMPRSS2), a gene regulated by androgens, for the priming of the viral protein peak, furin split, and the members of the renin–angiotensin–aldosterone system (RAAS). On the other hand, it has been shown that the inhibition of virus replication could be mediated by hydrogen bonding through the binding of amino acid residues [47,48] (Figure 3).
The peptides of a food origin can perform diverse bioactivities, including antiviral activities, depending on their characteristics and sequencing [49]. Therefore, the peptides derived from cereals could serve as inhibitors of multiple processes regarding the entry into the host cell and the viral replication of SARS-CoV-2. Diverse epidemiological studies highlight the importance of the consumption of diets rich in cereals and products of a natural origin that help to protect against hypertension and viral diseases such as COVID-19 [33,50,51].

5. Cereals as a Source of Compounds with Anti-Hypertensive Activity

The flavonoids and phenolic acids present in cereals have an ACE-inhibitory capacity mainly associated with blood pressure-lowering effects due to their antioxidant capacity [52]. The regulation of reactive oxygen species, the reduction in oxidative stress, and the formation of zinc chelates are factors that promote the lowering of blood pressure [53,54]. In Table 1, the in vivo or in vitro antihypertensive mechanisms of phenolic compounds present in some cereals are described.
In addition to phenolic compounds, studies have been conducted on multiple candidates for antihypertensive peptides, which, because of their biological activity, can be generated or incorporated into functional foods. Table 2 summarizes studies highlighting cereal peptides and proteins with antihypertensive activity. Proteins with a molecular weight lower than 1 kDa favor their entry through cell membranes enabling their absorption and circulation [64]. Hydrolyzed proteins with high levels of proline and other amino acids contribute to enzyme inhibition by chelation with zinc at the active center of the enzyme and its interaction with hydrophobic sites. Therefore, the ionic interaction between amino acids and zinc enhances the competitive activity for the catalytic sites of ACE [65,66]. Since there are antihypertensive peptides from cereals rich in proline and other hydrophilic amino acids related to the S protein of SARS-CoV-2, they could serve as multi-target inhibitors against host cell entry. The antihypertensive rice bran tripeptide Tyr-Ser-Lys, reported by Wang et al. [67], has two aliphatic amino acids in its chain with a hydroxyl in the C-terminal chain; thus, it could have antiviral effects. Similarly, the peptide Gly-Phe-Pro-Thr-Leu-Lys-Ile-Phe—reported by Gangopadhyay et al. [68]—in barley flour presents four hydrophilic amino acids, increasing the chances that it will be coupled to the S protein of the virus that causes COVID-19. An in silico study showed that some oligopeptides from barley, oats, wheat, and soybeans (PISCR, VQVVN, PQQQF, and EQQQR) were identified as potential binders of the SARS-CoV-2 spike protein receptor-binding domain (RBD) [69]. This feature is also observed in short-chain peptides isolated from cereals [70]. Antihypertensive peptides generally contain amino acid residues at the C-terminus or N-terminus. The presence of tyrosine, phenylalanine, tryptophan, proline, lysine, isoleucine, valine, leucine, and arginine present in the peptides influence the binding of the ACE substrate or inhibitor [71]. According to the reported studies, an association has been established between the presence of bioactive compounds and the ACE-inhibitory mechanism and this could have a significant impact on the active sites of SARS-CoV-2.

5.1. Rice

Wild rice (Zizania spp.) is one of the cereals that has presented anti-hypertensive, antiallergic, and immunomodulating activities, which are associated with the phenolic acids, flavonoids, and other phytochemicals with antioxidant properties that aid in the prevention of chronic illnesses [89,90]. Okarter and Liu [91] report that the low incidence of chronic diseases in regions where rice is consumed is related to the presence of phytochemical antioxidants in this cereal. Consequentially, these studies suggest the potential use of rice and its by-products in the prevention or contributory treatment of non-transmissible diseases such as hypertension.
Gong et al. [89] quantified the total phenolic content and flavonoids in different varieties of rice, such as black rice, red rice, whole rice, and plain rice. They reported concentrations of 1159, 669, 108.7, and 58.88 mg of Gallic Acid Equivalents (GAE)/100 g. With respect to the total content of flavonoids, the authors reported 1503, 598.2, 77.94, and 26.52 mg Quercetin Equivalents (QE)/100 g in black rice, red rice, whole rice, and plain rice. Deng et al. [92] demonstrated the antihypertensive effects of wild rice (Zizania latifolia) in spontaneously hypertensive rats, attributing these effects to the influence of the polyphenol content, principally quercetin, due to previous studies that have demonstrated that this compound reduces blood pressure and, moreover, since it presents protective effects against cardiovascular diseases. Table 1 shows the main mechanism used in the ACE inhibition of some phenolic compounds derived from cereals such as rice. The phytochemical composition of wild rice is so complex that the decrease in hypertension could be related to the synergic effects of bioactive compounds such as polyphenols and bioactive tripeptides [92,93].
Michelke et al. [72] evaluated possible ACE inhibitor peptides found in hydrolyzed whey, soy, and rice protein. The evaluation of ACE inhibition was performed in different ACE systems such as human plasma, venous endothelial cells from human umbilical cord, rabbit lungs, and rat aortic rings. The IC50 values observed in the soybean and rice peptide mixtures were approximately 2 to 2.5 times higher than the IC50 value of the serum-derived peptides. Therefore, the best ACE-inhibitory activity was from the serum peptides consisting of isoleucine and tryptophan.
Some studies have shown the effectiveness of dipeptides made up of isoleucine and tryptophan (IW) in decreasing ACE, showing anti-inflammatory and antioxidant activities in endothelial cells [94,95]. Lunow et al. [96] mention that the IW dipeptide acts as a competitive and selective inhibitor for the C-Terminal of ACE in plasma.
Jan-on et al. [54] demonstrated that virgin rice bran oil prevents hypertension induced by the L-NG-nitroarginine methyl ester (L-NAME) in rats, improving the hemodynamic alterations, as well as the reduction in oxidative stress and vascular inflammation. This suggests that these activities could be mediated by the content of unsaturated fat, antioxidants, phytochemicals such as g-oryzanol, phytosterols, and tocopherols, which possess antioxidant activities and provide vascular and inflammatory protection.
On the other hand, rice bran presents a high concentration of biologically active compounds that are important for human health, of which are found cellulose, hemicellulose, pectin, arabinoxylan, lignin, β-glucan, polyphenols, γ-oryzanol, β-sitosterol, vitamin B9, vitamin E, tocopherols, micronutrients (such as calcium and magnesium), and essential amino acids (such as arginine, cysteine, histidine, and tryptophan) [97].
Due to the high content of nutrients, a diet rich in rice increases immunological, antioxidant, anticancer, and antidiabetic activities, protecting the organism against multiple diseases [98]. Therefore, the use of these compounds and their different functions as collectors of free radicals, antiallergy agents, antiatherosclerosis agents, anti-influenza agents, anti-obesity agents, and antitumor agents offer protection against numerous chronic diseases and degenerative diseases in humans, including hypertension and some cases that could interfere with the infection of COVID-19.

5.2. Barley

In barley (Hordeum vulgare L), phytochemical concentrations have been reported in relation to a reduction in heart disease, colon cancer, gallstones, and cardiovascular illnesses [99]. The Food and Drug Administration reported that the intake of barley is related to a decrease in cardiovascular diseases [100], such as chronic coronary diseases, due to the decrease in plasma cholesterol promoted by β-glucans from hulled barley, which promote the excretion of fecal lipids [101].
Some of the properties that are attributed to barley for reducing the risk of cardiovascular diseases such as hypertension are related to their different bioactive components, which include peptides and ACE-inhibitory proteins [102]. However, some studies mention that the high inhibition of ACE is principally stimulated by the combination of components that come from antioxidants [103], peptides [68], or phenolic compounds [104].
Different authors have also demonstrated the great variety of bioactive compounds originating from barley [57,68], among which the most utilized are inhibitors of ACE. The total concentration of phenolic acids ranges between 604 and 1346 mg/g [105]. Kim et al. [106] studied the content of 127 varieties of barley with and without husks and they found that the flavonoid content ranged from 62–300.8 mg/g. Andersson et al. [107] studied 10 varieties of barley and found that the concentration of phytosterols ranges between 820 and 1153 mg/g. With respect to anthocyanins, the most common found in barley is the cyanidin 3-glucosidic type (214.8 mg/g) [108]. On the other hand, the lignans are the most studied polyphenols in barley, whose concentration ranges between 6.6 and 541 mg/100 g [109].
The peptides obtained from barley also present inhibitory effects towards ACE. The effects of the peptides occur principally because of the presence of hydrophobic peptides in the C-terminal chain of the peptide that are united in the active sites of ACE [68]. The presence of anthocyanins and polyphenols extracted from whole grains and seedlings of barley, respectively, have also been studied as potential inhibitors of ACE, presenting competitive and non-competitive inhibitory mechanisms. Some polyphenols show a non-competitive inhibition of ACE when a structural difference with the natural substrate of ACE is produced (Table 1) [57,58].
In addition to phenolic compounds and inhibitory peptides, the soluble fiber in barley and other cereals has an important role in human health. A study by Behall et al. [110] observed a reduction in systolic and diastolic blood pressure in middle-aged men and women after a 5-week integral diet. Fiber has anti-inflammatory effects, and in adults with asthma, an average fiber intake of 5 g/day plus a controlled mineral-rich diet is inversely associated with the eosinophilic inflammation of the respiratory tract and pulmonary function [111,112]. Epidemiological studies in humans have demonstrated that fiber can promote health and prevent chronic diseases, especially those related with inflammation [113], which could improve the cognitive function of people infected with COVID-19 [113]. Therefore, the intake of dietary fiber can support antiviral and immunosuppressive therapeutic treatments, thereby ameliorating the suffering of COVID-19 [114].

5.3. Corn

Across the globe, there are different varieties of corn, which is rich in fiber, vitamins, minerals, phenolic acids, flavonoids, sterols, and a great variety of phytochemicals [115]. There are reports that indicate that corn is one of the cereals with the highest availability of nutrients, mainly β-carotene and α-tocopherol, which suggests that it may be the most suitable for biofortification [116]. However, this may depend on the pigments in the grain. Blue, red, and purple corn have a higher concentration of anthocyanidins; in Chinese purple corn, approximate concentrations of 256.5 mg of cyanidin 3-glucoside/100 g at a dry weight have been reported, while in American corn, the anthokinin content ranges from 54 to 115 mg/100 g per sample [117,118]. Yellow corn is rich in carotenoids with a concentration of 0.823 mg/100 g per dry weight of corn [119]. Violeta et al. [116] have reported concentrations of 26.9 μg/g of β-carotene and 27.2 μg/g of α-tocopherol in dark orange corn grains, while in dark red corn, they were 2.51 and 4.95 μg/g, respectively, and in red corn, they only reported a concentration of α-tocopherol of 4.87 μg/g. Pigmented genotypes have shown a strong antioxidant capacity using DPPH and TEAC techniques [120]. In black corn, a higher antioxidant activity has been reported than in yellow and white corn [121]. According to reports, the type of phenolic compound and/or flavonoids are associated with grain pigmentation. The bioactive compounds have been related to antioxidant [122], anticancer [123], antimicrobial, and anti-viral activities [124]. The anthocyanin content differs by the variety of corn; in pink corn, it is approximately 12.74 mg of cyanidin 3-glucoside/100 g at a dry weight, while in black corn, the anthocyanin content is 304.5 mg of cyanidin 3-glucoside/100 g at a dry weight [118]. Corn has the highest antioxidant activity with 181.4 μmol equivalents of vitamin C/g per grain compared to cereals such as rice that have 55.77 μmol equivalents of vitamin C/g per grain, wheat with 76.70 μmol equivalents of vitamin C/g per grain, and oats with 74.67 μmol equivalents of vitamin C/g per grain [125].
Mellen et al. [126] carried out a metanalysis regarding the intake of whole grains and clinical cardiovascular events. According to their estimates, the consumption of whole cereals reduces the risk of suffering cardiovascular diseases by 21%. Similarly, this has been related to a decrease in the risks of suffering chronic diseases such as diabetes type 2 [127], obesity, some cancers [128,129], and cardiovascular diseases [130]. Wu et al. [74] evaluated the antihypertensive activity of ACE inhibitor peptides from corn germ using the hydroenzymatic lysis method with alkaline protease that allows for the production of a high concentration of inhibitor peptides. They carried out an ultrafiltration that allowed them to obtain smaller peptides of 6 kDa, increasing the IC50 of the inhibitory activity of ACE and demonstrating that the smaller the size the better absorption, according to the authors [7,75].
It has been reported that the peptides extracted from corn germ flour promote the balance between vasoconstrictor factors, vascular endurance, and the reduction in the level of renin and Angiotensin II, thus controlling blood pressure [73,74]. Huang et al. [75] demonstrated the antihypertensive effect of the peptides of corn in spontaneously hypertensive rats. They reported that two types of mechanisms of action exist in the peptide inhibitors of ACE: those that compete with the availability of the substrate of ACE and those that combine the bioactivity of ACE to inhibit its enzymatic activity. These are normally made up of more than four amino acids and from two to three amino acids. It is shown in this study that the molecular size of the inhibitory peptide of ACE plays an important role in its inhibitory activity because the peptides less than 3 kDa had an inhibition four times greater than the peptides of 5 kDa. In a dipeptide (Ala-Tyr) isolated from a hydrolyzed corn gluten flour, an IC50 of 82.92% was observed; therefore, due to its size, it is a potential ACE inhibitor [131]. Some peptides and proteins derived from cereals with antihypertensive activity are shown in the Table 2.
Duru [132] showed that the minerals and phytochemical content present in corn husks contribute to multiple health benefits. Among the most abundant minerals that can be found are calcium, sulfur, and potassium, which contribute to nerve and muscle regulation. This is the case for calcium; sulfur is present in different amino acids and potassium plays a part in the acid–base balance and osmotic regulation. As a consequence, a modification of the diet that includes the consumption of corn could be a strategy to prevent cardiovascular diseases and infectious diseases such as COVID-19.

5.4. Wheat

Wheat (Triticum spp.) has been used for the elaboration of basic foods since time immemorial and is highly essential in human nutrition, providing 55% of starch and more than 20% of food calories. Clinical studies have demonstrated that the regular consumption of wheat is associated with a reduction in chronic diseases, specifically the intake of dietetic fiber and other bioactive compounds [4].
Wheat is a rich source of diverse phytochemicals, among which are phenolic acids, terpenoids, tocopherols, and sterols [133]. The concentration of phenolic acids in whole wheat ranges between 200 to 1200 mg/g in dry weight [134]. The type of milling and the use given to this cereal has a great impact on the composition of the bioactive compounds and, thus, the health benefits as well as the improvement of the functions of the colon, those against cancer, those that protect against obesity, those that promote weight loss, and those that mitigate cardiovascular diseases [4,135].
Zhang et al. [66] isolated peptides from wheat gluten for their potential use as ACE inhibitors, showing the importance of generating gluten hydrolysates to increase their benefits, especially for the celiac population.
Besides gluten, wheat germ has widely been studied because of its high protein content. Diverse studies have demonstrated that the peptides isolated from wheat germ and some isolated from wheat gluten, such as VPL (Val-Pro-Leu), WL (Trp-Leu), WP (Trp-Pro), and IAP (Ile-Ala-Pro), present antihypertensive effects principally for ACE inhibition, which is caused principally by the high presence of hydrophobic amino acids such as proline and tryptophan (Table 2) [8,78,79].
Asoodeh et al. [77] performed a characterization of ACE-inhibitory peptides from wheat gluten protein hydrolysates through the use of trypsin. The sequences with the highest inhibitory activity were Ile-Pro-Ala-Leu-Leu-Lys-Arg and Ala-Gln-Gln-Leu-Ala-Ala-Gln-Leu-Pro-Arg-Met-Cys-Arg; as in most inhibitory peptides, this activity is influenced by the peptides’ structure, since some peptides that have tryptophan, tyrosine, phenylalanine, and proline residues and hydrophobic amino acids in the C-terminal sequence show greater inhibitory activity towards ACE [136].
Besides the extraction and evaluation of inhibitory peptides, Gammoh et al. [80] demonstrated that the isolation of phenols from protein fractions in wheat flour increased antihypertensive activity in an in an vitro model, alongside increasing antioxidant properties and decreasing allergenicity.
Recently, studies have demonstrated the capacity of polysaccharides to increase the immune response to infectious diseases. In cells such as macrophages, the polysaccharides activate the protein tracts, stimulating the control processes of the immune response [137]. Therefore, the polysaccharides of wheat induce the expression of cytokines, activating macrophages and increasing the phagocytotic activity [138,139]. Thus, the polysaccharides activate the important immunosuppression tracts for the treatment of persons infected with COVID-19 because they stimulate the production of anti-inflammatory substances, which could apply to the treatment of grave cases [137].

5.5. Oats

Oats (Avena sativa) are a whole cereal that provide proteins, unsaturated fatty acids, vitamins, minerals, dietetic fiber, and phenols such as the avenanthramides [140]. Soycan et al. [141] determined the concentration of phenolic acids and avenanthramides in commercial products of oats and showed that there was a greater concentration of these compounds (1518.6 μg/g) compared to oat bran (626.3 μg/g). Different bioactive compounds have been reported in oats, such as phenolic compounds, with a concentration between 180 and 576 mg Routine Equivalents (RE)/100 g. As to the phytosterols, oats present a concentration between approximately 35 and 68.2 mg/100 g. On the other hand, the tocopherol content (vitamin E) ranges between 0.5 and 3.61 mg/100 g [142].
Diverse studies mention that a regular consumption of oats reduces cholesterol [5,143], improves the sensitivity of insulin [144], and controls blood pressure [145]. Soyca et al. [141] reported a concentration of total phenolic acids of 39.5-62.75mg/100 g per sample. In this study, it is mentioned that ferulic acid is the principal component present in commercial oats, consisting of 58-78.1% of the total compounds. Ferulic acid presents antioxidant activities that can prevent chronic diseases [146]. It has been demonstrated that avenanthramides offer health benefits such as antioxidative properties that can help protect against cardiovascular diseases [147].
Few studies have investigated the benefits offered by oats in hypertension. However, their positive effects on cardiovascular diseases have not been discarded. Wang et al. [81] evaluated the ultrasonic pre-treatment of the protein in oats and its activity as a protein inhibitor of ACE, utilizing the enzymatic pre-treatment with ultrasound for the improvement of the hydrolysis of proteins and the process of enzymolysis for the liberation of peptides less than 3kDa. The results showed that the ultrasonic energy, the duration of treatment, and the time of enzymolysis greatly influenced the hydrolysis grade and inhibitory activities of the ACE of the peptides. They showed that the inhibition of ACE provoked by the peptides had an increase of 32.1 to 53.8% compared to samples without ultrasonic treatment. According to the authors, the rate of enzymatic hydrolysis after ultrasonic pre-treatment was due to the increase in the affinity between the alcalase and the isolated protein. Alcalase is a specific endonuclease enzyme that combines exposed hydrophobic sides, which could have brought about an increase in the production of inhibitor peptides of ACE, provoked by the high grade of the hydrolysis it promoted [148].
Besides the protein inhibitors of ACE, the soluble fibers such as the β-glucans of oats have been widely studied, demonstrating prebiotic effects and improving glycemic control and regulating blood pressure [149,150]. Maki et al. [151] evaluated the effect of the consumption of foods that contain the β-glucan from oats in blood pressure. The study consisted of a controlled randomized clinical trial, which was double blinded, where 97 men and women, with a mean age of 63 years, systolic blood pressure of 130–179 mmHg, and/or a diastolic blood pressure of 85–109 mm Hg were assigned to consume foods containing oat β-glucan or control foods for 12 weeks. Although the results did not show a significant difference in terms of the decrease in blood pressure between the groups, the decrease in blood pressure significantly decreased both the systolic (8.3 mm Hg, p = 0.008) and diastolic (3, 9 mm Hg, p = 0.018) pressure in the subjects with a body mass index above the mean (31.5 kg/m2) compared to the control groups.
The extracts of β-glucans produce immunomodulatory effects and pulmonary cryoprotections, which could have therapeutic implications in patients with COVID-19. In the same way, these could reduce oxidative stress and activate macrophages [33].
McCarty and DiNicolantonio [152] recently described the potential role of β-glucan as a natural nutraceutical to boost the response of interferon type 1 to RNA viruses such as the influenza and the coronavirus. Therefore, the intake of oat products provides a rich source of phytochemicals that provides health benefits such as decreasing high blood pressure and influencing the immunotherapies against infections such as COVID-19 due to the presence of inhibitory peptides of ACE and of β-glucans.

5.6. Millet

Millet includes numerous species that are not related genetically. However, it contains various phytochemicals, phenolic compounds, phytosterols, policosanols, and bioactive peptides [153]. Chandrasekara and Shahidi [154] evaluated different varieties of this cereal that presented approximate concentrations of hydroxybenzoic and hydroxycinnamic acids and their by-products from 9.3 to 62.2 µg/g and 9.1 to 173 µg/g of defatted flour, respectively, both in their free forms. As to flavonoids, this cereal contains from 2 to 100 mg/g, which differs because of the variety of the species [153]
The protein of foxtail millet (Setaria italica Beauv) can have physicochemical and physiological properties. Some studies have found that foxtail millet presents antioxidant activities, reduces the levels of cholesterol, and can present anticancer effects [155,156].
Furthermore, foxtail millet presents antihypertensive effects. Studies reported the inhibitory capacity of the ACE of hydrolyzed proteins derived from this cereal [87]. The consumption of whole grains can reduce blood pressure. Hou et al. [88] reported that the consumption of 50 g of whole grains of pulverized foxtail millet extruded in the form of bread or millet pancakes for 12 weeks showed a significant reduction in SBP of 133.61 and 129.48 mmHg, as well as a reduction in the mass index and body fat in 45 middle-aged hypertensive patients. However, Chen et al. [87] showed the best results with respect to decreasing blood pressure. In this study, they used spontaneously hypertensive rats. They showed that a diet of 200 mg of peptides per kg of body weight for four weeks reduces blood pressure via the intake of raw samples and in extruded and fermented samples with Rhizopus oryzae. Compared to the extruded and fermented samples, the raw samples caused a greater decrease in blood pressure with a reduction of 28.3 mmHg in PAS. As to the extruded and fermented hydrolyzed proteins, there was a reduction of 24.8 and 13.6 mmHg, respectively. A controlled group treated with captopril had a reduction of 23.6 mmHg.
Therefore, the consumption of foxtail millet protein, specifically hydrolyzed, raw, and extruded millet protein, improves hypertension due to the antioxidant and anti-inflammatory properties whereby vascular conditions can be regulated gradually (Table 2) [157]. In both studies, the levels of ACE and Ang II decreased, which could indicate that the antihypertensive mechanism of foxtail millet consists of inhibiting the activity of the ACE in the serum of subjects with slight hypertension. The antihypertensive effects produced by cereals are related to the improvement in the endothelial function that is achieved by inhibiting the effects of vasoconstrictors such as Ang II, inducing vasodilatation through nitric oxide, and affecting the vasorelaxation tracts involved. Along with the previously mentioned cereal, the consumption of millet can aid the modulation of immune functions, which helps to protect against the COVID-19 ailment [158].

5.7. Rye

Among cereals, rye (Secale cereale L.) contains the highest concentration of dietetic fiber, which is composed of arabinoxylan, cellulose, β-glucan, fructans, and lignin. Arabinoxylan is the most abundant fiber in rye (7.6–12.1% of the dry grain weight) [159]. Pihlava et al. [160] reported 0.5, 4.6, and 20.5 mg/100 g of dry weight of total flavonoids present in the fine flour of rye, whole rye flour, and rye bran, respectively. As to the quantity of anthocyanins, the authors reported 0.15 mg/100 g in rye bran, 0.18 mg/100 g in whole rye flour, and 0.026 mg/100 g in fine rye flour. They also reported 66.3, 15.5, and 291.6 mg/100 g in the dry weight of alkylresorcinols in whole rye flour, fine rye flour, and rye bran, respectively.
There is important evidence within the studies of the physiological effects of rye foods with possible health benefits, such as the positive effects on tumors in prostate cancer [2], antihyperglycemic properties, and antihypertensive activities [86]. Zhao et al. [86] evaluated the concentration of inhibitors of the ACE of different bakery products starting with rye sourdough. They reported eight ACE-inhibitory tripeptides. The dominant tripeptide was IPP (Ile-Pro-Pro) with 58 to 73 mmol/kg. Moreover, the peptide that showed the greatest inhibition of ACE was LPP (Leu-Pro-Pro) (57 mmol/L), which is characterized by the presence of leucine, an amino acid with a greater hydrophobicity, which is a principal characteristic of the inhibitors of ACE.
Rye grains are a source of diverse phytochemicals such as phenolic acids, lignans, and alkylresorcinols [160]. Multiple studies have demonstrated the capacity of the secondary metabolites of plants to generate antiviral activities besides the importance of phytochemicals against SARS-CoV [161,162]. There are studies that link the effectiveness of dietary fiber to the prevention of diseases related to lifestyle such as hypertension [163,164]. Dietary fibers reach the colon and produce short-chain fatty acids, which are released into the circulation to reach the organs involved in the regulation of hypertension [165]. Due to the high content of dietary fiber, proteins, and various bioactive compounds, rye can enhance immunomodulatory and antihypertensive activities.

5.8. Sorghum

Sorghum (Sorghum spp.) contains tannins, phenolic acids, anthocyanins, and phytosterols. These phytochemicals have the potential to provide a significant impact on human health, promoting cardiovascular health by reducing the plasma levels of lipoproteins of a low density and hepatic cholesterol [166]. Sorghum contains benzoic acids and cinnamic acids, which range from 16 to 131 mg/g and from 41 to 444 mg/g, respectively [167].
Anthocyanins are the most studied flavonoids in sorghum; Awika et al. [168] reported that the anthocyanin content in black sorghum bran is three to four times higher than in whole grain and had at least twice the anthocyanin levels (10.1 mg/g) in comparison with red sorghum (3.6 mg/g). The quantitative data of the phytosterols present in sorghum are limited, although approximate contents of 44 to 72 mg/100 g have been reported [169,170].
The generation of ACE-inhibitory peptides has been carried out in different forms. Most of these techniques were based on the production of peptides from food proteins via enzymatic hydrolysis [66]. Wu et al. [84] developed a kinetic method that describes the enzymatic hydrolysis of the protein of sweet sorghum grain utilizing alcalase to purify ACE-inhibitory peptides (Table 2). The authors demonstrated that 19% hydrolysis exhibited the strongest inhibitory activity of ACE. On the other hand, they obtained a tripeptide inhibitor composed of Threonina (Thr)-Leucine (Leu)-Serine (Ser), which, due to the serine union at the C-terminal of the chain, manages to interact in the peak protein subunits (S1 and S2) of ACE, thereby achieving its inhibition. Some studies explained the relationship between the structure and the activity of the inhibitory peptides of ACE, which are influenced by the C-terminal and the presence of hydrophobic amino acids or aromatic residues such as Tryptophan (Trp), Tyrosine (Tyr), Proline (Pro), and Phenylalanine (Phe). However, this structure-activity relationship has not been completely established [148].
The polyphenols have an ample antiviral activity against diverse groups of viruses such as influenza A (H1N1), hepatitis B and C (VHB/VHC), herpes simplex 1 (VHS-1), human immunodeficiency virus (HIV) and, recently, the virus that caused the COVID-19 disease (SARS-CoV-2) [171].
Besides their antiviral capacity, the phenolic compounds can also present antihypertensive activity. Irondi et al. [61] analyzed raw and toasted red sorghum grain flour (150 and 180 °C) to determine the inhibitory activities of different enzymes including ACE. They found that the raw grains showed high inhibitory activities (19.64 μg/mL) because of the high presence of phenolic acids (gallic, chlorogenic, caffeic, ellagic, and p-coumaric) and flavonoids (quercetin, luteolin, and apigenin), as increasing the temperature when toasting decreases the presence of phenolic compounds and, consequentially, causes a decrease in inhibitory activity, with an IC50 in the grains roasted at 150 °C of 20.99 μg/mL and in the grains roasted at 180 °C of 22.81 μg/mL. Therefore, the parallel decrease in the inhibitory activity of the enzymes and the phenolic composition of the grains with the increase in the toasting temperature suggests that the phenolic acids and the flavonoids could be the principal inhibitors of the enzymes of the grain.
In this way, sorghum is a cereal with high potential to control hypertension and, in some cases, its consumption could reduce the probability of viral infection by SARS-CoV-2 due to its high phytochemical content. In general, this cereal seems to have a great potential to form part of a healthy diet and its consumption as grains or as food products could reinforce the bioavailability of nutrients to prevent chronic diseases and infections.

6. Conclusions

Different components of cereals have been characterized, such as anthocyanins, flavonoids, phenolic acids, proteins, and fibers, which have biological activities that help prevent or control hypertension acting on the RAAS, inflammation, and oxidative stress. According to the studies reported in this review, pigmented raw rice exhibits the greatest ACE inhibition. In an in vitro study, raw rice was shown to inhibit up to 97% of ACE. This activity is related to the reduction in oxidative stress and the reduction in NOS, caused by the presence of phenolic compounds such as proanthocyanidins. In silico studies showed that peptides derived from oats, made up mainly of aromatic amino acids, can inhibit up to 96.5% of ACE. The presence of this type of amino acid is also related to the ability to inhibit the TMPRSS protease of the host to prevent the entry of the SARS-CoV-2 virus. ACE inhibitor drugs (ACEi) and angiotensin II receptor blockers (ARBs) participate in processes that regulate the expression of ACE2, thus being useful in the treatment of patients who developed SARS-CoV-2. Ultimately, this review highlighted the mechanisms used by bioactive compounds in cereals to lower blood pressure and how these processes could be involved in reducing the degree of COVID-19 infection.

Author Contributions

Conceptualization, A.D.R.-G. and F.A.G.-O.; Methodology, A.G.-C.; Validation, A.C.-O. and R.C.-C.; Formal Analysis, P.L.-P.; Investigation, A.D.R.-G. and F.A.G.-O.; Resources, O.A.A.-S.; Data Curation, A.C.-O.; Writing—Original Draft Preparation, A.G.-C., A.D.R.-G.; Writing—Review & Editing, A.D.R.-G., F.A.G.-O., A.C.-O. and R.C.-C.; Visualization, P.L.-P.; Supervision, A.D.R.-G.; Project Administration, A.D.R.-G. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article.

Acknowledgments

This research manuscript was supported by CONACyT. The manuscript was written with contributions from all authors. All the authors have given approval of the final version of the manuscript. All the authors confirmed there is no conflicts of interest.

Conflicts of Interest

No conflict of interest among authors.

References

  1. Björck, I.; Östman, E.; Kristensen, M.; Mateo Anson, N.; Price, R.K.; Haenen, G.R.M.M.; Havenaar, R.; Bach Knudsen, K.E.; Frid, A.; Mykkänen, H.; et al. Cereal grains for nutrition and health benefits: Overview of results from in vitro, animal and human studies in the HEALTHGRAIN project. Trends Food Sci. Technol. 2012, 25, 87–100. [Google Scholar] [CrossRef]
  2. Zamaratskaia, G.; Mhd Omar, N.A.; Brunius, C.; Hallmans, G.; Johansson, J.-E.; Andersson, S.-O.; Larsson, A.; Åman, P.; Landberg, R. Consumption of whole grain/bran rye instead of refined wheat decrease concentrations of TNF-R2, e-selectin, and endostatin in an exploratory study in men with prostate cancer. Clin. Nutr. 2020, 39, 159–165. [Google Scholar] [CrossRef]
  3. Alu’Datt, M.H.; Ereifej, K.; Abu-Zaiton, A.; Alrababah, M.; Almajwal, A.; Rababah, T.; Yang, W. Anti-oxidant, anti-diabetic, and anti-hypertensive effects of extracted phenolics and hydrolyzed peptides from barley protein fractions. Int. J. Food Prop. 2012, 15, 781–795. [Google Scholar] [CrossRef]
  4. Gupta, R.; Meghwal, M.; Prabhakar, P.K. Bioactive compounds of pigmented wheat (Triticum aestivum): Potential benefits in human health. Trends Food Sci. Technol. 2021, 110, 240–252. [Google Scholar] [CrossRef]
  5. Ho, H.V.T.; Sievenpiper, J.L.; Zurbau, A.; Blanco Mejia, S.; Jovanovski, E.; Au-Yeung, F.; Jenkins, A.L.; Vuksan, V. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: A systematic review and meta-analysis of randomised-controlled trials. Br. J. Nutr. 2016, 116, 1369–1382. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Kim, B.; Woo, S.; Kim, M.-J.; Kwon, S.-W.; Lee, J.; Sung, S.H.; Koh, H.-J. Identification and quantification of flavonoids in yellow grain mutant of rice (Oryza sativa L.). Food Chem. 2018, 241, 154–162. [Google Scholar] [CrossRef] [PubMed]
  7. Chai, T.-T.; Law, Y.-C.; Wong, F.-C.; Kim, S.-K. Enzyme-Assisted Discovery of Antioxidant Peptides from Edible Marine Invertebrates: A Review. Mar. Drugs 2017, 15, 42. [Google Scholar] [CrossRef]
  8. Cavazos, A.; Gonzalez de Mejia, E. Identification of Bioactive Peptides from Cereal Storage Proteins and Their Potential Role in Prevention of Chronic Diseases. Compr. Rev. Food Sci. Food Saf. 2013, 12, 364–380. [Google Scholar] [CrossRef] [PubMed]
  9. Esfandi, R.; Walters, M.E.; Tsopmo, A. Antioxidant properties and potential mechanisms of hydrolyzed proteins and peptides from cereals. Heliyon 2019, 5, e01538. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Komolafe, K.; Akinmoladun, A.C.; Komolafe, T.R.; Olaleye, M.T.; Boligon, A.A.; Akindahunsi, A.A.; Rocha, J.B.T. Angiotensin-1-converting enzyme inhibition, antioxidant activity, and modulation of cerebral Na+/K+ ATPase by free phenolics of African locust bean (Parkia biglobosa). Health Sci. Rep. 2017, 1, e17. [Google Scholar] [CrossRef]
  11. Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. [Google Scholar] [CrossRef] [Green Version]
  12. Walls, A.C.; Park, Y.-J.; Tortorici, M.A.; Wall, A.; McGuire, A.T.; Veesler, D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 2020, 181, 281.e6–292.e6. [Google Scholar] [CrossRef] [PubMed]
  13. Soler, M.J.; Ye, M.; Wysocki, J.; William, J.; Lloveras, J.; Batlle, D. Localization of ACE2 in the renal vasculature: Amplification by angiotensin II type 1 receptor blockade using telmisartan. Am. J. Physiol. Ren. Physiol. 2009, 296, F398–F405. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Wang, X.; Ye, Y.; Gong, H.; Wu, J.; Yuan, J.; Wang, S.; Yin, P.; Ding, Z.; Kang, L.; Jiang, Q.; et al. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1–7)-Mas axes in pressure overload-induced cardiac remodeling in male mice. J. Mol. Cell. Cardiol. 2016, 97, 180–190. [Google Scholar] [CrossRef]
  15. Baptiste, D.-L.; Hamilton, J.B.; Foronda, C.; Sloand, E.; Fahlberg, B.; Pfaff, T.; Delva, S.; Davidson, P.M. Hypertension among adults living in Haiti: An integrative review. J. Clin. Nurs. 2018, 27, 2536–2545. [Google Scholar] [CrossRef]
  16. Iqbal, A.M.; Jamal, S.F. Essential Hypertension. Available online: https://www.ncbi.nlm.nih.gov/books/NBK539859/ (accessed on 27 January 2021).
  17. Patel, S.; Rauf, A.; Khan, H.; Abu-Izneid, T. Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies. Biomed. Pharmacother. 2017, 94, 317–325. [Google Scholar] [CrossRef]
  18. Larsen, M.K.; Matchkov, V.V. Hypertension and physical exercise: The role of oxidative stress. Medicina 2016, 52, 19–27. [Google Scholar] [CrossRef]
  19. Small, H.Y.; Migliarino, S.; Czesnikiewicz-Guzik, M.; Guzik, T.J. Hypertension: Focus on autoimmunity and oxidative stress. Free Radic. Biol. Med. 2018, 125, 104–115. [Google Scholar] [CrossRef]
  20. Schulz, E.; Gori, T.; Münzel, T. Oxidative stress and endothelial dysfunction in hypertension. Hypertens. Res. Off. J. Jpn. Soc. Hypertens. 2011, 34, 665–673. [Google Scholar] [CrossRef]
  21. Ganguly, A.; Sharma, K.; Majumder, K. Chapter Four—Food-derived bioactive peptides and their role in ameliorating hypertension and associated cardiovascular diseases. In Advances in Food and Nutrition Research; Toldrá, F., Ed.; Academic Press: Cambridge, MA, USA, 2019; Volume 89, pp. 165–207. ISBN 1043-4526. [Google Scholar]
  22. Carey, R.M.; Muntner, P.; Bosworth, H.B.; Whelton, P.K. Prevention and Control of Hypertension: JACC Health Promotion Series. J. Am. Coll. Cardiol. 2018, 72, 1278–1293. [Google Scholar] [CrossRef]
  23. Pons, Z.; Margalef, M.; Bravo, F.I.; Arola-Arnal, A.; Muguerza, B. Chronic administration of grape-seed polyphenols attenuates the development of hypertension and improves other cardiometabolic risk factors associated with the metabolic syndrome in cafeteria diet-fed rats. Br. J. Nutr. 2017, 117, 200–208. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Kim, J.H.; Auger, C.; Kurita, I.; Anselm, E.; Rivoarilala, L.O.; Lee, H.J.; Lee, K.W.; Schini-Kerth, V.B. Aronia melanocarpa juice, a rich source of polyphenols, induces endothelium-dependent relaxations in porcine coronary arteries via the redox-sensitive activation of endothelial nitric oxide synthase. Nitric Oxide 2013, 35, 54–64. [Google Scholar] [CrossRef] [PubMed]
  25. Taleb, H.; Morris, K.; Withycombe, C.E.; Maddocks, S.E.; Kanekanian, A.D. Date syrup–derived polyphenols attenuate angiogenic responses and exhibits anti-inflammatory activity mediated by vascular endothelial growth factor and cyclooxygenase-2 expression in endothelial cells. Nutr. Res. 2016, 36, 636–647. [Google Scholar] [CrossRef] [PubMed]
  26. Wang, P.-H.; Cheng, Y. Increasing Host Cellular Receptor—Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV Infection. bioRxiv 2020, 92, 2696–2701. [Google Scholar] [CrossRef] [Green Version]
  27. Zhao, Y.; Zhao, Z.; Wang, Y.; Zhou, Y.; Ma, Y.; Zuo, W. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. bioRxiv 2020, 202, 756–759. [Google Scholar] [CrossRef] [PubMed]
  28. Choi, S.-I.; Hwang, S.W. Depolarizing Effectors of Bradykinin Signaling in Nociceptor Excitation in Pain Perception. Biomol. Ther. 2018, 26, 255–267. [Google Scholar] [CrossRef] [PubMed]
  29. Bavishi, C.; Maddox, T.M.; Messerli, F.H. Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers. JAMA Cardiol. 2020, 5, 745–747. [Google Scholar] [CrossRef] [Green Version]
  30. Devaux, C.A.; Rolain, J.-M.; Raoult, D. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J. Microbiol. Immunol. Infect. 2020, 53, 425–435. [Google Scholar] [CrossRef]
  31. Furuhashi, M.; Moniwa, N.; Mita, T.; Fuseya, T.; Ishimura, S.; Ohno, K.; Shibata, S.; Tanaka, M.; Watanabe, Y.; Akasaka, H.; et al. Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker. Am. J. Hypertens. 2015, 28, 15–21. [Google Scholar] [CrossRef] [Green Version]
  32. Gaskins, A.J.; Mumford, S.L.; Rovner, A.J.; Zhang, C.; Chen, L.; Wactawski-Wende, J.; Perkins, N.J.; Schisterman, E.F.; BioCycle Study Group. Whole grains are associated with serum concentrations of high sensitivity C-reactive protein among premenopausal women. J. Nutr. 2010, 140, 1669–1676. [Google Scholar] [CrossRef] [Green Version]
  33. Murphy, E.J.; Masterson, C.; Rezoagli, E.; O’Toole, D.; Major, I.; Stack, G.D.; Lynch, M.; Laffey, J.G.; Rowan, N.J. β-Glucan extracts from the same edible shiitake mushroom Lentinus edodes produce differential in-vitro immunomodulatory and pulmonary cytoprotective effects—Implications for coronavirus disease (COVID-19) immunotherapies. Sci. Total Environ. 2020, 732, 139330. [Google Scholar] [CrossRef] [PubMed]
  34. Goletzke, J.; Buyken, A.E.; Joslowski, G.; Bolzenius, K.; Remer, T.; Carstensen, M.; Egert, S.; Nöthlings, U.; Rathmann, W.; Roden, M.; et al. Increased Intake of Carbohydrates from Sources with a Higher Glycemic Index and Lower Consumption of Whole Grains during Puberty Are Prospectively Associated with Higher IL-6 Concentrations in Younger Adulthood among Healthy Individuals. J. Nutr. 2014, 144, 1586–1593. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Herder, C.; Peltonen, M.; Koenig, W.; Sütfels, K.; Lindström, J.; Martin, S.; Ilanne-Parikka, P.; Eriksson, J.G.; Aunola, S.; Keinänen-Kiukaanniemi, S.; et al. Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia 2009, 52, 433–442. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Braude, P.; Carter, B.; Short, R.; Vilches-Moraga, A.; Verduri, A.; Pearce, L.; Price, A.; Quinn, T.J.; Stechman, M.; Collins, J.; et al. The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19. IJC Heart Vasc. 2020, 31, 100660. [Google Scholar] [CrossRef]
  37. Singh, A.K.; Gupta, R.; Misra, A. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes Metab. Syndr. Clin. Res. Rev. 2020, 14, 283–287. [Google Scholar] [CrossRef] [PubMed]
  38. Wan, Y.; Shang, J.; Graham, R.; Baric, R.S.; Li, F. Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J. Virol. 2020, 94, e00127-20. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  39. Martínez-del Río, J.; Piqueras-Flores, J.; Nieto-Sandoval Martín de la Sierra, P.; Negreira-Caamaño, M.; Águila-Gordo, D.; Mateo-Gómez, C.; Salas-Bravo, D.; Rodríguez-Martínez, M. Análisis de la relación entre los inhibidores del sistema renina-angiotensina y la evolución de pacientes hospitalizados por infección respiratoria COVID-19. Med. Clínica 2020, 155, 473–481. [Google Scholar] [CrossRef] [PubMed]
  40. Guo, J.; Huang, Z.; Lin, L.; Lv, J. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infe. J. Am. Heart Assoc. 2020, 9, e016219. [Google Scholar] [CrossRef]
  41. Reddy, R.; Asante, I.; Liu, S.; Parikh, P.; Liebler, J.; Borok, Z.; Rodgers, K.; Baydur, A.; Louie, S.G. Circulating angiotensin peptides levels in Acute Respiratory Distress Syndrome correlate with clinical outcomes: A pilot study. PLoS ONE 2019, 14, e0213096. [Google Scholar] [CrossRef]
  42. Hoffmann, M.; Kleine-Weber, H.; Schroeder, S.; Krüger, N.; Herrler, T.; Erichsen, S.; Schiergens, T.S.; Herrler, G.; Wu, N.-H.; Nitsche, A.; et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 2020, 181, 271.e8–280.e8. [Google Scholar] [CrossRef]
  43. Gheblawi, M.; Wang, K.; Viveiros, A.; Nguyen, Q.; Zhong, J.C.; Turner, A.J.; Raizada, M.K.; Grant, M.B.; Oudit, G.Y. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System. Circ. Res. 2020, 126, 1456–1474. [Google Scholar] [CrossRef] [PubMed]
  44. Chen, H.; Du, Q. Potential natural compounds for preventing SARS-CoV-2 (2019-nCoV) infection. Preprints 2020. [Google Scholar] [CrossRef] [Green Version]
  45. Liu, W.; Zheng, W.; Cheng, L.; Li, M.; Huang, J.; Bao, S.; Xu, Q.; Ma, Z. Citrus Fruits Are Rich in Flavonoids for Immunoregulation and Potential Targeting ACE2. Natural Products and Bioprospecting 2022, 12, 4. [Google Scholar] [CrossRef]
  46. Yan, Y.-M.; Shen, X.; Cao, Y.-K.; Zhang, J.-J.; Wang, Y.; Cheng, Y.-X. Discovery of Anti-2019-nCoV Agents from Chinese Patent Drugs via Docking Screening. Preprints 2020. [Google Scholar] [CrossRef] [Green Version]
  47. Chourasia, R.; Padhi, S.; Chiring Phukon, L.; Abedin, M.M.; Singh, S.P.; Rai, A.K. A Potential Peptide from Soy Cheese Produced Using Lactobacillus delbrueckii WS4 for Effective Inhibition of SARS-CoV-2 Main Protease and S1 Glycoprotein. Front. Mol. Biosci. 2020, 7, 601753. [Google Scholar] [CrossRef] [PubMed]
  48. Zhao, W.; Li, X.; Yu, Z.; Wu, S.; Ding, L.; Liu, J. Identification of lactoferrin-derived peptides as potential inhibitors against the main protease of SARS-CoV-2. LWT 2022, 154, 112684. [Google Scholar] [CrossRef] [PubMed]
  49. Agarwal, G.; Gabrani, R. Antiviral Peptides: Identification and Validation. Int. J. Pept. Res. Ther. 2021, 27, 149–168. [Google Scholar] [CrossRef]
  50. Borneo, R.; León, A.E. Whole grain cereals: Functional components and health benefits. Food Funct. 2012, 3, 110–119. [Google Scholar] [CrossRef]
  51. Iddir, M.; Brito, A.; Dingeo, G.; Fernandez Del Campo, S.S.; Samouda, H.; La Frano, M.R.; Bohn, T. Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis. Nutrients 2020, 12, 1562. [Google Scholar] [CrossRef]
  52. Rodrigo, R.; Prat, H.; Passalacqua, W.; Araya, J.; Bächler, J.P. Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension. Clin. Sci. 2008, 114, 625–634. [Google Scholar] [CrossRef]
  53. Cian, R.E.; Caballero, M.S.; Sabbag, N.; González, R.J.; Drago, S.R. Bio-accessibility of bioactive compounds (ACE inhibitors and antioxidants) from extruded maize products added with a red seaweed Porphyra columbina. LWT Food Sci. Technol. 2014, 55, 51–58. [Google Scholar] [CrossRef]
  54. Jan-on, G.; Sangartit, W.; Pakdeechote, P.; Kukongviriyapan, V.; Sattayasai, J.; Senaphan, K.; Kukongviriyapan, U. Virgin rice bran oil alleviates hypertension through the upregulation of eNOS and reduction of oxidative stress and in flammation in L-NAME À induced hypertensive rats. Nutrition 2020, 69, 110575. [Google Scholar] [CrossRef] [PubMed]
  55. Massaretto, I.L.; Madureira Alves, M.F.; Mussi de Mira, N.V.; Carmona, A.K.; Lanfer Marquez, U.M. Phenolic compounds in raw and cooked rice (Oryza sativa L.) and their inhibitory effect on the activity of angiotensin I-converting enzyme. J. Cereal Sci. 2011, 54, 236–240. [Google Scholar] [CrossRef]
  56. Pannangpetch, P.; Tangsucharit, P.; Thanaruksa, R.; Proongkhong, T.; Srisuwan, S.; Aekthammarat, D. Antihypertensive effect of Mali-Nil surin rice bran hydrolysate and its mechanisms related to the EDHF-mediated vasorelaxation and L-type Ca2+ channel-mediated vasoconstriction in L-NAME hypertensive rats. Biomed. Pharmacother. 2022, 150, 113003. [Google Scholar] [CrossRef]
  57. Ra, J.E.; Woo, S.Y.; Jin, H.; Lee, M.J.; Kim, H.Y.; Ham, H.; Chung, I.M. Evaluation of antihypertensive polyphenols of barley (Hordeum vulgare L.) seedlings via their effects on angiotensin—Converting enzyme (ACE) inhibition. Appl. Biol. Chem. 2020, 63, 38. [Google Scholar] [CrossRef]
  58. Lee, C.; Han, D.; Kim, B.; Baek, N.; Baik, B. Antioxidant and anti-hypertensive activity of anthocyanin-rich extracts from hulless pigmented barley cultivars. Food Sci. Technol. 2013, 48, 984–991. [Google Scholar] [CrossRef]
  59. Ayyash, M.; Johnson, S.K.; Liu, S.; Mheiri, A.A.; Abushelaibi, A. Cytotoxicity, antihypertensive, antidiabetic and antioxidant activities of solid-state fermented lupin, quinoa and wheat by Bifidobacterium species: In-vitro investigations. LWT-Food Sci. Technol. 2018, 95, 295–302. [Google Scholar] [CrossRef]
  60. Reque, P.M.; Orlandini Werner, J.A.; Barreto Pinilla, C.M.; Folmer Corrêa, A.P.; Rodrigues, E.; Brandelli, A. Biological activities of wheat middlings bioprocessed with Bacillus spp. LWT 2017, 77, 525–531. [Google Scholar] [CrossRef]
  61. Irondi, E.A.; Adegoke, B.M.; Effion, E.S.; Oyewo, S.O.; Alamu, E.O.; Boligon, A.A. Enzymes inhibitory property, antioxidant activity and phenolics profile of raw and roasted red sorghum grains in vitro. Food Sci. Hum. Wellness 2019, 8, 142–148. [Google Scholar] [CrossRef]
  62. Arouna, N.; Gabriele, M.; Pucci, L. The Impact of Germination on Sorghum Nutraceutical Properties. Foods 2020, 9, 1218. [Google Scholar] [CrossRef]
  63. Kwon, Y.-I.; Apostolidis, E.; Kim, Y.-C.; Shetty, K. Health Benefits of Traditional Corn, Beans, and Pumpkin: In Vitro Studies for Hyperglycemia and Hypertension Management. J. Med. Food 2007, 10, 266–275. [Google Scholar] [CrossRef]
  64. Roberts, P.R.; Burney, J.D.; Black, K.W.; Zaloga, G.P. Effect of Chain Length on Absorption of Biologically Active Peptides from the Gastrointestinal Tract. Digestion 1999, 60, 332–337. [Google Scholar] [CrossRef]
  65. Aluko, R.E. Structure and function of plant protein-derived antihypertensive peptides. Curr. Opin. Food Sci. 2015, 4, 44–50. [Google Scholar] [CrossRef]
  66. Zhang, P.; Chang, C.; Liu, H.; Li, B.; Yan, Q.; Jiang, Z. Identification of novel angiotensin I-converting enzyme (ACE) inhibitory peptides from wheat gluten hydrolysate by the protease of Pseudomonas aeruginosa. J. Funct. Foods 2020, 65, 103751. [Google Scholar] [CrossRef]
  67. Wang, X.; Chen, H.; Fu, X.; Li, S.; Wei, J. A novel antioxidant and ACE inhibitory peptide from rice bran protein: Biochemical characterization and molecular docking study. Food Sci. Technol. 2017, 75, 93–99. [Google Scholar] [CrossRef]
  68. Gangopadhyay, N.; Wynne, K.; Connor, P.O.; Gallagher, E.; Brunton, N.P.; Rai, D.K.; Hayes, M. In silico and in vitro analyses of the angiotensin-I converting enzyme inhibitory activity of hydrolysates generated from crude barley (Hordeum vulgare) protein concentrates. Food Chem. 2016, 203, 367–374. [Google Scholar] [CrossRef] [Green Version]
  69. Luo, Z.; Su, K.; Zhang, X. Potential of Plant Proteins Digested In Silico by Gastrointestinal Enzymes as Nutritional Supplement for COVID-19 Patients. Plant Foods Hum. Nutr. 2020, 75, 583–591. [Google Scholar] [CrossRef]
  70. Ejike, C.E.C.C.; Collins, S.A.; Balasuriya, N.; Swanson, A.K.; Mason, B.; Udenigwe, C.C. Prospects of microalgae proteins in producing peptide-based functional foods for promoting cardiovascular health. Trends Food Sci. Technol. 2017, 59, 30–36. [Google Scholar] [CrossRef]
  71. Guang, C.; Phillips, R.D. Plant food-derived Angiotensin I converting enzyme inhibitory peptides. J. Agric. Food Chem. 2009, 57, 5113–5120. [Google Scholar] [CrossRef] [PubMed]
  72. Michelke, L.; Deussen, A.; Dieterich, P.; Martin, M. Effects of bioactive peptides encrypted in whey-, soy- and rice protein on local and systemic angiotensin-converting enzyme activity. J. Funct. Foods 2017, 28, 299–305. [Google Scholar] [CrossRef]
  73. Guo, Y.; Wang, K.; Wu, B.; Wu, P.; Duan, Y.; Ma, H. Production of ACE inhibitory peptides from corn germ meal by an enzymatic membrane reactor with a novel gradient diafiltration feeding working-mode and in vivo evaluation of antihypertensive effect. J. Funct. Foods 2020, 64, 103584. [Google Scholar] [CrossRef]
  74. Wu, D.; Ren, J.; Song, C. Optimization of Enzymatic Hydrolysis of Corn Germ Meal to Prepare ACE Inhibitory Peptides. Sci. Technol. Cereals Oils Foods 2014, 22, 51–53. [Google Scholar]
  75. Huang, W.H.; Sun, J.; He, H.; Dong, H.W.; Li, J.T. Antihypertensive effect of corn peptides, produced by a continuous production in enzymatic membrane reactor, in spontaneously hypertensive rats. Food Chem. 2011, 128, 968–973. [Google Scholar] [CrossRef]
  76. Lin, F.; Chen, L.; Liang, R.; Zhang, Z.; Wang, J.; Cai, M.; Li, Y. Pilot-scale production of low molecular weight peptides from corn wet milling byproducts and the antihypertensive effects in vivo and in vitro. Food Chem. 2011, 124, 801–807. [Google Scholar] [CrossRef]
  77. Asoodeh, A.; Haghighi, L.; Chamani, J.; Ansari-Ogholbeyk, M.A.; Mojallal-Tabatabaei, Z.; Lagzian, M. Potential angiotensin I converting enzyme inhibitory peptides from gluten hydrolysate: Biochemical characterization and molecular docking study. J. Cereal Sci. 2014, 60, 92–98. [Google Scholar] [CrossRef]
  78. Qu, W.; Ma, H.; Zhao, W.; Pan, Z. ACE-inhibitory peptides production from defatted wheat germ protein by continuous coupling of enzymatic hydrolysis and membrane separation: Modeling and experimental studies. Chem. Eng. J. 2013, 226, 139–145. [Google Scholar] [CrossRef]
  79. Jia, J.; Ma, H.; Zhao, W.; Wang, Z.; Tian, W.; Luo, L.; He, R. The use of ultrasound for enzymatic preparation of ACE-inhibitory peptides from wheat germ protein. Food Chem. 2010, 119, 336–342. [Google Scholar] [CrossRef]
  80. Gammoh, S.; Alu’datt, M.H.; Alhamad, M.N.; Rababah, T.; Al-Mahasneh, M.; Qasaimeh, A.; Johargy, A.; Kubow, S.; Hussein, N.M. The effects of protein-phenolic interactions in wheat protein fractions on allergenicity, antioxidant activity and the inhibitory activity of angiotensin I-converting enzyme (ACE). Food Biosci. 2018, 24, 50–55. [Google Scholar] [CrossRef]
  81. Wang, B.; Atungulu, G.G.; Khir, R. Ultrasonic Treatment Effect on Enzymolysis Kinetics and Activities of ACE-Inhibitory Peptides from Oat-Isolated Protein. Food Biophysics. 2015, 10, 244–252. [Google Scholar] [CrossRef]
  82. Bleakley, S.; Hayes, M.; O’ Shea, N.; Gallagher, E.; Lafarga, T. Predicted Release and Analysis of Novel ACE-I, Renin, and DPP-IV Inhibitory Peptides from Common Oat (Avena sativa) Protein Hydrolysates Using in Silico Analysis. Foods 2017, 6, 108. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Cheung, I.W.Y.; Nakayama, S.; Hsu, M.N.K.; Samaranayaka, A.G.P.; Li-Chan, E.C.Y. Angiotensin-I Converting Enzyme Inhibitory Activity of Hydrolysates from Oat (Avena sativa) Proteins by In Silico and In Vitro Analyses. J. Agric. Food Chem. 2009, 57, 9234–9242. [Google Scholar] [CrossRef] [PubMed]
  84. Wu, Q.; Du, J.; Jia, J.; Kuang, C. Production of ACE inhibitory peptides from sweet sorghum grain protein using alcalase: Hydrolysis kinetic, purification and molecular docking study. Food Chem. 2016, 199, 140–149. [Google Scholar] [CrossRef]
  85. Kamath, V.; Niketh, S.; Chandrashekar, A.; Rajini, P.S. Chymotryptic hydrolysates of α-kafirin, the storage protein of sorghum (Sorghum bicolor) exhibited angiotensin converting enzyme inhibitory activity. Food Chem. 2007, 100, 306–311. [Google Scholar] [CrossRef]
  86. Zhao, C.J.; Hu, Y.; Schieber, A.; Gänzle, M. Fate of ACE-inhibitory peptides during the bread-making process: Quanti fi cation of peptides in sourdough, bread crumb, steamed bread and soda crackers. J. Cereal Sci. 2013, 57, 514–519. [Google Scholar] [CrossRef]
  87. Chen, J.; Duan, W.; Ren, X.; Wang, C.; Pan, Z.; Diao, X.; Shen, Q. Effect of foxtail millet protein hydrolysates on lowering blood pressure in spontaneously hypertensive rats. Eur. J. Nutr. 2017, 56, 2129–2138. [Google Scholar] [CrossRef] [PubMed]
  88. Hou, D.; Chen, J.; Ren, X.; Wang, C.; Diao, X.; Hu, X.; Zhang, Y.; Shen, Q. A whole foxtail millet diet reduces blood pressure in subjects with mild hypertension. J. Cereal Sci. 2018, 84, 13–19. [Google Scholar] [CrossRef]
  89. Gong, E.S.; Liu, C.; Li, B.; Zhou, W.; Chen, H.; Li, T.; Wu, J.; Zeng, Z.; Wang, Y.; Si, X.; et al. Phytochemical profiles of rice and their cellular antioxidant activity against ABAP induced oxidative stress in human hepatocellular carcinoma HepG2 cells. Food Chem. 2020, 318, 126484. [Google Scholar] [CrossRef]
  90. Yu, X.; Chu, M.; Chu, C.; Du, Y.; Shi, J.; Liu, X.; Liu, Y.; Zhang, H.; Zhang, Z.; Yan, N. Wild rice (Zizania spp.): A review of its nutritional constituents, phytochemicals, antioxidant activities, and health-promoting effects. Food Chem. 2020, 331, 127293. [Google Scholar] [CrossRef] [PubMed]
  91. Okarter, N.; Liu, R.H. Health Benefits of Whole Grain Phytochemicals. Crit. Rev. Food Sci. Nutr. 2010, 50, 193–208. [Google Scholar] [CrossRef]
  92. Deng, Y.; Luo, Y.; Qian, B.; Liu, Z.; Zheng, Y.; Song, X.; Lai, S.; Zhao, Y. Antihypertensive effect of few-flower wild rice (Zizania latifolia Turcz.) in spontaneously hypertensive rats. Food Sci. Biotechnol. 2014, 23, 439–444. [Google Scholar] [CrossRef]
  93. Duarte, J.; Pérez-Palencia, R.; Vargas, F.; Ocete, M.A.; Pérez-Vizcaino, F.; Zarzuelo, A.; Tamargo, J. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br. J. Pharmacol. 2001, 133, 117–124. [Google Scholar] [CrossRef] [PubMed]
  94. Gu, Y.; Liang, Y.; Bai, J.; Wu, W.; Lin, Q.; Wu, J. Spent hen-derived ACE inhibitory peptide IWHHT shows antioxidative and anti-inflammatory activities in endothelial cells. J. Funct. Foods 2019, 53, 85–92. [Google Scholar] [CrossRef]
  95. Kopaliani, I.; Martin, M.; Zatschler, B.; Müller, B.; Deussen, A. Whey peptide Isoleucine-Tryptophan inhibits expression and activity of matrix metalloproteinase-2 in rat aorta. Peptides 2016, 82, 52–59. [Google Scholar] [CrossRef]
  96. Lunow, D.; Kaiser, S.; Rückriemen, J.; Pohl, C.; Henle, T. Tryptophan-containing dipeptides are C-domain selective inhibitors of angiotensin converting enzyme. Food Chem. 2015, 166, 596–602. [Google Scholar] [CrossRef] [PubMed]
  97. Tuncel, N.B.; Yılmaz, N. Gamma-oryzanol content, phenolic acid profiles and antioxidant activity of rice milling fractions. Eur. Food Res. Technol. 2011, 233, 577. [Google Scholar] [CrossRef]
  98. Verma, D.K.; Srivastav, P.P. Bioactive compounds of rice (Oryza sativa L.): Review on paradigm and its potential benefit in human health. Trends Food Sci. Technol. 2020, 97, 355–365. [Google Scholar] [CrossRef]
  99. Idehen, E.; Tang, Y.; Sang, S. Bioactive phytochemicals in barley. J. Food Drug Anal. 2016, 25, 148–161. [Google Scholar] [CrossRef] [Green Version]
  100. FDA. New Hope Network. Available online: https://www.newhope.com/supply-news-amp-analysis/fda-finalizes-health-claim-associating-consumption-barley-products-reductio (accessed on 4 October 2021).
  101. Topping, D.; Morell, M. Chapter 9—Barley foods and public health. In American Associate of Cereal Chemists International, 2nd ed.; Shewry, P.R., Ullrich, S.E.B.T.-B., Eds.; AACC International Press: Washington, DC, USA, 2014; pp. 223–231. ISBN 978-1-891127-79-3. [Google Scholar]
  102. Huang, W.; Davidge, S.; Wu, J. Bioactive Natural Constituents from Food Sources—Potential Use in Hypertension Prevention and Treatment. Crit. Rev. Food Sci. Nutr. 2013, 53, 615–630. [Google Scholar] [CrossRef]
  103. Mirzaei, M.; Mirdamadi, S.; Ehsani, M.R.; Aminlari, M.; Hosseini, E. Purification and identification of antioxidant and ACE-inhibitory peptide from Saccharomyces cerevisiae protein hydrolysate. J. Funct. Foods 2015, 19, 259–268. [Google Scholar] [CrossRef]
  104. Mamilla, R.K.; Mishra, V.K. Effect of germination on antioxidant and ACE inhibitory activities of legumes. LWT-Food Sci. Technol. 2017, 75, 51–58. [Google Scholar] [CrossRef]
  105. Holtekjølen, A.K.; Kinitz, C.; Knutsen, S.H. Flavanol and Bound Phenolic Acid Contents in Different Barley Varieties. J. Agric. Food Chem. 2006, 54, 2253–2260. [Google Scholar] [CrossRef] [PubMed]
  106. Kim, M.-J.; Hyun, J.-N.; Kim, J.-A.; Park, J.-C.; Kim, M.-Y.; Kim, J.-G.; Lee, S.-J.; Chun, S.-C.; Chung, I.-M. Relationship between Phenolic Compounds, Anthocyanins Content and Antioxidant Activity in Colored Barley Germplasm. J. Agric. Food Chem. 2007, 55, 4802–4809. [Google Scholar] [CrossRef] [PubMed]
  107. Andersson, A.A.M.; Lampi, A.-M.; Nyström, L.; Piironen, V.; Li, L.; Ward, J.L.; Gebruers, K.; Courtin, C.M.; Delcour, J.A.; Boros, D.; et al. Phytochemical and dietary fiber components in barley varieties in the HEALTHGRAIN Diversity Screen. J. Agric. Food Chem. 2008, 56, 9767–9776. [Google Scholar] [CrossRef]
  108. Bellido, G.G.; Beta, T. Anthocyanin composition and oxygen radical scavenging capacity (ORAC) of milled and pearled purple, black, and common barley. J. Agric. Food Chem. 2009, 57, 1022–1028. [Google Scholar] [CrossRef] [PubMed]
  109. Smeds, A.I.; Eklund, P.C.; Sjöholm, R.E.; Willför, S.M.; Nishibe, S.; Deyama, T.; Holmbom, B.R. Quantification of a broad spectrum of lignans in cereals, oilseeds, and nuts. J. Agric. Food Chem. 2007, 55, 1337–1346. [Google Scholar] [CrossRef] [PubMed]
  110. Behall, K.M.; Scholfield, D.J.; Hallfrisch, J. Whole-grain diets reduce blood pressure in mildly hypercholesterolemic men and women. J. Am. Diet. Assoc. 2006, 106, 1445–1449. [Google Scholar] [CrossRef]
  111. Berthon, B.S.; Macdonald-Wicks, L.K.; Gibson, P.G.; Wood, L.G. Investigation of the association between dietary intake, disease severity and airway inflammation in asthma. Respirology 2013, 18, 447–454. [Google Scholar] [CrossRef] [Green Version]
  112. Williams, L.M.; Scott, H.A.; Wood, L.G. Soluble fibre as a treatment for inflammation in asthma. J. Nutr. Intermed. Metab. 2019, 18, 100108. [Google Scholar] [CrossRef]
  113. Collier, M.E.W.; Zhang, S.; Scrutton, N.S.; Giorgini, F. Inflammation control and improvement of cognitive function in COVID-19 infections: Is there a role for kynurenine 3-monooxygenase inhibition? Drug Discov. Today 2021, 26, 1473–1481. [Google Scholar] [CrossRef]
  114. Conte, L.; Toraldo, D.M. Targeting the gut–lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infection. Adv. Respir. Dis. 2020, 14, 1753466620937170. [Google Scholar] [CrossRef]
  115. Abirami, S.; Priyalakshmi, M.; Soundariya, A.; Samrot, A.V.; Saigeetha, S.; Emilin, R.R.; Dhiva, S.; Inbathamizh, L. Antimicrobial activity, antiproliferative activity, amylase inhibitory activity and phytochemical analysis of ethanol extract of corn (Zea mays L.) silk. Curr. Res. Green Sustain. Chem. 2021, 4, 100089. [Google Scholar] [CrossRef]
  116. Andjelkovic, V.; Vukadinović, J.; Srebric, M.; Mladenović-Drinić, S. Pigmented maize—A potential source of β-carotene and α-tocopherol. J. Eng. Process. Manag. 2019, 10, 1–7. [Google Scholar] [CrossRef]
  117. Moreno, Y.S.; Sánchez, G.S.; Hernández, D.R.; Lobato, N.R. Characterization of anthocyanin extracts from maize kernels. J. Chromatogr. Sci. 2005, 43, 483–487. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  118. Zhao, X.; Zhang, C.; Guigas, C.; Ma, Y.; Corrales, M.; Tauscher, B.; Hu, X. Composition, antimicrobial activity, and antiproliferative capacity of anthocyanin extracts of purple corn (Zea mays L.) from China. Eur. Food Res. Technol. 2009, 228, 759–765. [Google Scholar] [CrossRef]
  119. Scott, C.E.; Eldridge, A.L. Comparison of carotenoid content in fresh, frozen and canned corn. J. Food Compos. Anal. 2005, 18, 551–559. [Google Scholar] [CrossRef]
  120. Lopez-Martinez, L.X.; Oliart-Ros, R.M.; Valerio-Alfaro, G.; Lee, C.-H.; Parkin, K.L.; Garcia, H.S. Antioxidant activity, phenolic compounds and anthocyanins content of eighteen strains of Mexican maize. LWT-Food Sci. Technol. 2009, 42, 1187–1192. [Google Scholar] [CrossRef]
  121. Hu, Q.; Xu, J. Profiles of Carotenoids, Anthocyanins, Phenolics, and Antioxidant Activity of Selected Color Waxy Corn Grains during Maturation. J. Agric. Food Chem. 2011, 59, 2026–2033. [Google Scholar] [CrossRef]
  122. Van Hung, P. Phenolic Compounds of Cereals and Their Antioxidant Capacity. Crit. Rev. Food Sci. Nutr. 2016, 56, 25–35. [Google Scholar] [CrossRef]
  123. Brglez Mojzer, E.; Knez Hrnčič, M.; Škerget, M.; Knez, Ž.; Bren, U. Polyphenols: Extraction Methods, Antioxidative Action, Bioavailability and Anticarcinogenic Effects. Molecules 2016, 21, 901. [Google Scholar] [CrossRef]
  124. Buzzini, P.; Arapitsas, P.; Goretti, M.; Branda, E.; Turchetti, B.; Pinelli, P.; Romani, F.I. Annalisa Antimicrobial and Antiviral Activity of Hydrolysable Tannins. Mini-Rev. Med. Chem. 2008, 8, 1179–1187. [Google Scholar] [CrossRef]
  125. Adom, K.K.; Liu, R.H. Antioxidant activity of grains. J. Agric. Food Chem. 2002, 50, 6182–6187. [Google Scholar] [CrossRef]
  126. Mellen, P.B.; Walsh, T.F.; Herrington, D.M. Whole grain intake and cardiovascular disease: A meta-analysis. Nutr. Metab. Cardiovasc. Dis. 2008, 18, 283–290. [Google Scholar] [CrossRef] [PubMed]
  127. Ye, E.Q.; Chacko, S.A.; Chou, E.L.; Kugizaki, M.; Liu, S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J. Nutr. 2012, 142, 1304–1313. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  128. Mourouti, N.; Kontogianni, M.D.; Papavagelis, C.; Psaltopoulou, T.; Kapetanstrataki, M.G.; Plytzanopoulou, P.; Vassilakou, T.; Malamos, N.; Linos, A.; Panagiotakos, D.B. Whole Grain Consumption and Breast Cancer: A Case-Control Study in Women. J. Am. Coll. Nutr. 2016, 35, 143–149. [Google Scholar] [CrossRef] [PubMed]
  129. Schatzkin, A.; Mouw, T.; Park, Y.; Subar, A.F.; Kipnis, V.; Hollenbeck, A.; Leitzmann, M.F.; Thompson, F.E. Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. Am. J. Clin. Nutr. 2007, 85, 1353–1360. [Google Scholar] [CrossRef] [Green Version]
  130. Tighe, P.; Duthie, G.; Vaughan, N.; Brittenden, J.; Simpson, W.G.; Duthie, S.; Mutch, W.; Wahle, K.; Horgan, G.; Thies, F. Effect of increased consumption of whole-grain foods on blood pressure and other cardiovascular risk markers in healthy middle-aged persons: A randomized controlled trial. Am. J. Clin. Nutr. 2010, 92, 733–740. [Google Scholar] [CrossRef] [Green Version]
  131. Yang, Y.; Tao, G.; Liu, P.; Liu, J. Peptide with Angiotensin I-Converting Enzyme Inhibitory Activity from Hydrolyzed Corn Gluten Meal. J. Agric. Food Chem. 2007, 55, 7891–7895. [Google Scholar] [CrossRef] [PubMed]
  132. Duru, C.E. Mineral and phytochemical evaluation of Zea mays husk. Sci. Afr. 2020, 7, e00224. [Google Scholar] [CrossRef]
  133. Luthria, D.L.; Lu, Y.; John, K.M.M. Bioactive phytochemicals in wheat: Extraction, analysis, processing, and functional properties. J. Funct. Foods 2015, 18, 910–925. [Google Scholar] [CrossRef]
  134. Andersson, A.A.M.; Dimberg, L.; Åman, P.; Landberg, R. Recent findings on certain bioactive components in whole grain wheat and rye. J. Cereal Sci. 2014, 59, 294–311. [Google Scholar] [CrossRef]
  135. Wieser, H.; Koehler, P.; Scherf, K.A. (Eds.) Chapter 6—Nutritional value of wheat. In Wheat—An Exceptional Crop; Woodhead Publishing: Sawston, UK, 2020; pp. 133–148. ISBN 978-0-12-821715-3. [Google Scholar]
  136. Kim, S.-K.; Ngo, D.-H.; Vo, T.-S. Chapter 16—Marine Fish-Derived Bioactive Peptides as Potential Antihypertensive Agents. In Marine Medicinal Foods; Kim, S.-K., Ed.; Academic Press: Cambridge, MA, USA, 2012; Volume 65, pp. 249–260. ISBN 1043-4526. [Google Scholar]
  137. Barbosa, J.R.; de Carvalho Junior, R.N. Occurrence and possible roles of polysaccharides in fungi and their influence on the development of new technologies. Carbohydr. Polym. 2020, 246, 116613. [Google Scholar] [CrossRef] [PubMed]
  138. Deng, C.; Fu, H.; Shang, J.; Chen, J.; Xu, X. Dectin-1 mediates the immunoenhancement effect of the polysaccharide from Dictyophora indusiata. Int. J. Biol. Macromol. 2018, 109, 369–374. [Google Scholar] [CrossRef] [PubMed]
  139. Shen, T.; Wang, G.; You, L.; Zhang, L.; Ren, H.; Hu, W.; Qiang, Q.; Wang, X.; Ji, L.; Gu, Z.; et al. Polysaccharide from wheat bran induces cytokine expression via the toll-like receptor 4-mediated p38 MAPK signaling pathway and prevents cyclophosphamide-induced immunosuppression in mice. Food Nutr. Res. 2017, 61, 1344523. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  140. Singh, R.; De, S.; Belkheir, A. Avena sativa (Oat), a potential neutraceutical and therapeutic agent: An overview. Crit. Rev. Food Sci. Nutr. 2013, 53, 126–144. [Google Scholar] [CrossRef]
  141. Soycan, G.; Schär, M.Y.; Kristek, A.; Boberska, J.; Alsharif, S.N.S.; Corona, G.; Shewry, P.R.; Spencer, J.P.E. Composition and content of phenolic acids and avenanthramides in commercial oat products: Are oats an important polyphenol source for consumers? Food Chem. X 2019, 3, 100047. [Google Scholar] [CrossRef] [PubMed]
  142. Raguindin, P.F.; Adam Itodo, O.; Stoyanov, J.; Dejanovic, G.M.; Gamba, M.; Asllanaj, E.; Minder, B.; Bussler, W.; Metzger, B.; Muka, T.; et al. A systematic review of phytochemicals in oat and buckwheat. Food Chem. 2021, 338, 127982. [Google Scholar] [CrossRef]
  143. Grundy, M.M.-L.; Fardet, A.; Tosh, S.M.; Rich, G.T.; Wilde, P.J. Processing of oat: The impact on oat’s cholesterol lowering effect. Food Funct. 2018, 9, 1328–1343. [Google Scholar] [CrossRef] [Green Version]
  144. Bao, L.; Cai, X.; Xu, M.; Li, Y. Effect of oat intake on glycaemic control and insulin sensitivity: A meta-analysis of randomised controlled trials. Br. J. Nutr. 2014, 112, 457–466. [Google Scholar] [CrossRef]
  145. Zhu, Y.; Dong, L.; Huang, L.; Shi, Z.; Dong, J.; Yao, Y.; Shen, R. Effects of oat β-glucan, oat resistant starch, and the whole oat flour on insulin resistance, inflammation, and gut microbiota in high-fat-diet-induced type 2 diabetic rats. J. Funct. Foods 2020, 69, 103939. [Google Scholar] [CrossRef]
  146. Kumar, N.; Pruthi, V. Potential applications of ferulic acid from natural sources. Biotechnol. Rep. 2014, 4, 86–93. [Google Scholar] [CrossRef] [Green Version]
  147. Rao, S.; Santhakumar, A.B.; Chinkwo, K.A.; Blanchard, C.L. Investigation of phenolic compounds with antioxidant activity in barley and oats affected by variation in growing location. Cereal Chem. 2020, 97, 772–782. [Google Scholar] [CrossRef]
  148. He, R.; Malomo, S.A.; Alashi, A.; Girgih, A.T.; Ju, X.; Aluko, R.E. Purification and hypotensive activity of rapeseed protein-derived renin and angiotensin converting enzyme inhibitory peptides. J. Funct. Foods 2013, 5, 781–789. [Google Scholar] [CrossRef]
  149. Dong, J.; Yang, M.; Zhu, Y.; Shen, R.; Zhang, K. Comparative study of thermal processing on the physicochemical properties and prebiotic effects of the oat β-glucan by in vitro human fecal microbiota fermentation. Food Res. Int. 2020, 138, 109818. [Google Scholar] [CrossRef]
  150. Pino, J.L.; Mujica, V.; Arredondo, M. Effect of dietary supplementation with oat β-glucan for 3 months in subjects with type 2 diabetes: A randomized, double-blind, controlled clinical trial. J. Funct. Foods 2021, 77, 104311. [Google Scholar] [CrossRef]
  151. Maki, K.C.; Galant, R.; Samuel, P.; Tesser, J.; Witchger, M.S.; Ribaya-Mercado, J.D.; Blumberg, J.B.; Geohas, J. Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure. Eur. J. Clin. Nutr. 2007, 61, 786–795. [Google Scholar] [CrossRef] [Green Version]
  152. McCarty, M.F.; DiNicolantonio, J.J. Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus. Prog. Cardiovasc. Dis. 2020, 63, 383–385. [Google Scholar] [CrossRef]
  153. Duodu, K.G.; Awika, J.M. Chapter 8—Phytochemical-Related Health-Promoting Attributes of Sorghum and Millets. In Sorghum and Millets, 2nd ed.; Taylor, J.R.N., Duodu, K.G., Eds.; AACC International Press: Washington, DC, USA, 2019; pp. 225–258. ISBN 978-0-12-811527-5. [Google Scholar]
  154. Chandrasekara, A.; Shahidi, F. Determination of antioxidant activity in free and hydrolyzed fractions of millet grains and characterization of their phenolic profiles by HPLC-DAD-ESI-MSn. J. Funct. Foods 2011, 3, 144–158. [Google Scholar] [CrossRef]
  155. Choi, Y.-Y.; Osada, K.; Ito, Y.; Nagasawa, T.; Choi, M.-R.; Nishizawa, N. Effects of dietary protein of Korean foxtail millet on plasma adiponectin, HDL-cholesterol, and insulin levels in genetically type 2 diabetic mice. Biosci. Biotechnol. Biochem. 2005, 69, 31–37. [Google Scholar] [CrossRef] [PubMed]
  156. Shan, S.; Li, Z.; Newton, I.P.; Zhao, C.; Li, Z.; Guo, M. A novel protein extracted from foxtail millet bran displays anti-carcinogenic effects in human colon cancer cells. Toxicol. Lett. 2014, 227, 129–138. [Google Scholar] [CrossRef] [PubMed]
  157. Majumder, K.; Panahi, S.; Kaufman, S.; Wu, J. Fried egg digest decreases blood pressure in spontaneous hypertensive rats. J. Funct. Foods 2013, 5, 187–194. [Google Scholar] [CrossRef]
  158. Baksi, A.J.; Treibel, T.A.; Davies, J.E.; Hadjiloizou, N.; Foale, R.A.; Parker, K.H.; Francis, D.P.; Mayet, J.; Hughes, A.D. A meta-analysis of the mechanism of blood pressure change with aging. J. Am. Coll. Cardiol. 2009, 54, 2087–2092. [Google Scholar] [CrossRef] [PubMed]
  159. Izydorczyk, M.S. Functional properties of cereal cell wall polysaccharides. In Carbohydrates in Food; CRC Press: Boca Raton, FL, USA, 2017; pp. 215–278. ISBN 978-1-315-37282-2. [Google Scholar]
  160. Pihlava, J.-M.; Hellström, J.; Kurtelius, T.; Mattila, P. Flavonoids, anthocyanins, phenolamides, benzoxazinoids, lignans and alkylresorcinols in rye (Secale cereale) and some rye products. J. Cereal Sci. 2018, 79, 183–192. [Google Scholar] [CrossRef]
  161. Wen, C.-C.; Kuo, Y.-H.; Jan, J.-T.; Liang, P.-H.; Wang, S.-Y.; Liu, H.-G.; Lee, C.-K.; Chang, S.-T.; Kuo, C.-J.; Lee, S.-S.; et al. Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus. J. Med. Chem. 2007, 50, 4087–4095. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  162. Bhushan, I.; Sharma, M.; Mehta, M.; Badyal, S.; Sharma, V.; Sharma, I.; Singh, H.; Sistla, S. Bioactive compounds and probiotics–a ray of hope in COVID-19 management. Food Sci. Hum. Wellness 2021, 10, 131–140. [Google Scholar] [CrossRef]
  163. Wouk, J.; Dekker, R.F.H.; Queiroz, E.A.I.F.; Barbosa-Dekker, A.M. β-Glucans as a panacea for a healthy heart? Their roles in preventing and treating cardiovascular diseases. Int. J. Biol. Macromol. 2021, 177, 176–203. [Google Scholar] [CrossRef]
  164. Xue, Y.; Cui, L.; Qi, J.; Ojo, O.; Du, X.; Liu, Y.; Wang, X. The effect of dietary fiber (oat bran) supplement on blood pressure in patients with essential hypertension: A randomized controlled trial. Nutr. Metab. Cardiovasc. Dis. 2021, 31, 2458–2470. [Google Scholar] [CrossRef] [PubMed]
  165. Jayachandran, M.; Chen, J.; Chung, S.S.M.; Xu, B. A critical review on the impacts of β-glucans on gut microbiota and human health. J. Nutr. Biochem. 2018, 61, 101–110. [Google Scholar] [CrossRef] [PubMed]
  166. Althwab, S.; Carr, T.P.; Weller, C.L.; Dweikat, I.M.; Schlegel, V. Advances in grain sorghum and its co-products as a human health promoting dietary system. Food Res. Int. 2015, 77, 349–359. [Google Scholar] [CrossRef]
  167. Chiremba, C.; Taylor, J.R.N.; Rooney, L.W.; Beta, T. Phenolic acid content of sorghum and maize cultivars varying in hardness. Food Chem. 2012, 134, 81–88. [Google Scholar] [CrossRef] [Green Version]
  168. Awika, J.M.; Rooney, L.W.; Waniska, R.D. Anthoycanins from black sorghum and their antioxidant properties. Food Chem. 2004, 90, 293–301. [Google Scholar] [CrossRef]
  169. Bean, S.R.; Wilson, J.D.; Moreau, R.A.; Galant, A.; Awika, J.M.; Kaufman, R.C.; Adrianos, S.L.; Ioerger, B.P. Structure and Composition of the Sorghum Grain. Sorghum 2019, 58, 173–214. [Google Scholar] [CrossRef]
  170. Bhandari, S.; Lee, Y.-S. The Contents of Phytosterols, Squalene, and Vitamin E and the Composition of Fatty Acids of Korean Landrace Setaria italica and Sorghum bicolar Seeds. Korean J. Plant Resour. 2013, 26, 663–672. [Google Scholar] [CrossRef] [Green Version]
  171. Paraiso, I.L.; Revel, J.S.; Stevens, J.F. Potential use of polyphenols in the battle against COVID-19. Curr. Opin. Food Sci. 2020, 32, 149–155. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Renin–angiotensin–aldosterone system. Created with BioRender.com (accessed on 5 October 2022).
Figure 1. Renin–angiotensin–aldosterone system. Created with BioRender.com (accessed on 5 October 2022).
Foods 11 03231 g001
Figure 2. Phenol binding to the ACE2 receptor and protein S blockade of SARS-CoV-2. Created with BioRender.com (accessed on 28 August 2022).
Figure 2. Phenol binding to the ACE2 receptor and protein S blockade of SARS-CoV-2. Created with BioRender.com (accessed on 28 August 2022).
Foods 11 03231 g002
Figure 3. Peptide activity on SARS-CoV-2: (1) Inhibition of TMRPSS2 by bioactive peptides blocks priming of virus S proteins. (2) Inhibition of protein S by amino acid residues through hydrogen bonds prevents SARS-CoV-2 virus’ entry. Created with BioRender.com (accessed on 28 August 2022).
Figure 3. Peptide activity on SARS-CoV-2: (1) Inhibition of TMRPSS2 by bioactive peptides blocks priming of virus S proteins. (2) Inhibition of protein S by amino acid residues through hydrogen bonds prevents SARS-CoV-2 virus’ entry. Created with BioRender.com (accessed on 28 August 2022).
Foods 11 03231 g003
Table 1. Phenolic compounds derived from cereals with antihypertensive activity.
Table 1. Phenolic compounds derived from cereals with antihypertensive activity.
FoodMain Phenolic CompoundTestIC50 or % IECADecrease
BP
Main MechanismReference
Virgin rice bran oilSterols, tocopherols, and tocotrienolsin vivoND25.5%Regulation of NOS and reduction in oxidative stress[54]
Raw ricePhenol acids
Flavonoids
in vitro97%NDCompetitive inhibition of ECA[55]
Rice bran hydrolysatePhenolic compoundsin vivoND31.5%Endothelium-derived hyperpolarizing factor-mediated vasorelaxation and L-type Ca 2+ channel-mediated vasoconstriction[56]
Barley seedlingsPolyphenolsin vitro66.5%NDNon-competitive inhibitors of ECA and formation of chelates with ions of zinc[57]
Barley whole grainAnthocyaninsin vitro8770 µg/mLNDNatural competitive inhibitors of ECA[58]
Barley bran4540 µg/mL
Solid-state fermented wheatPhenolic compoundsin vitro53.8%NDInhibition of ECA by proteolysis[59]
Bioprocessed wheat middlingsPhenolic compoundsin vitro94.9%NDThe hydrolysis of short chain peptides increases ECA- inhibitory capacity[60]
Sorghum roasted grainPhenolic acids and flavonoidsin vitro20.99 µg/mLNDHydrogen and the hydrophobic union caused by the denaturation of enzymes[61]
Sorghum grainsPhenolic compoundsin vitro46.3%NDProduction of peptides and free amino acids before germination increases ECA-inhibitory activity[62]
Extruded maize products added with a red seaweedPhenolic compoundsin vitro41%NDECA inhibition trough sequestration of enzyme metal factor Zn2+[53]
Water extracts of maizeSoluble phenolsin vitro50%NDSmall peptide compounds may represent the bioactive factors contributing to the total ECA-inhibitory activity[63]
BP: Blood Pressure; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; % IECA: Percent inhibition of ECA; ND: Not determined.
Table 2. Peptides derived from cereals with antihypertensive activity.
Table 2. Peptides derived from cereals with antihypertensive activity.
FoodBioactive CompoundMWTestIC50 or % IECADecrease BPMain MechanismReference
Bran of ricePeptide<4 kDain vitro30 µg/mLNDReducer and inhibitor of ECA[67]
Rice protein hydrolysatesDipeptidesNDin vitro76.58-µg/mLNDBlocker of ECA due to the presence of aromatic amino acids[72]
Barley flourPeptide <3 kDain vitro70.3%NDInhibitors of ECA via the presence of hydrophobic amino acids[68]
Corn germ flourPeptide<3 kDain vivo830 µg/mL15.7%Regulation of vasoconstrictors increases in NO and prostacyclin decreases in Ang II[73]
Corn germ Peptides<6 kDain vitro1389 µg/mLNDInhibitory effect on ECA[74]
Corn gluten flourPeptides<3 kDain vivo/in vitro290 µg/mL>30 mmHg
SBP
Persistent inhibition of the ECA in tissues[75]
Corn gluten flour DipeptideND in vivo-in vitro37 µg/mL35–45 mmHg
SBP
Inhibitor of ECA by possible synergy between peptides[76]
Hydrolyzed wheat gluten Peptides<1 kDain vitro2 µg/mLNDInhibition of ECA by electrostatic interactions and interactions with hydrogen bonds [66]
Hydrolyzed wheat glutenPeptides<1 kDain vitro4 µg/mLNDCompetitive and non-competitive inhibitors of ECA[77]
Defatted wheat germ Peptides<5 kDa in vitro452 µg/mLNDInhibition of ECA by enzymolysis and ionization of proteins[78]
Defatted wheat germHydrolyzed proteinsND in vitro220 µg/mLNDInhibition of ECA by hydrophobic amino acids[79]
Wheat flourPhenolics from peptide fractionsNDin vitro84.52%NDInhibition of ECA by bound phenols after acid hydrolysis[80]
Oat-isolated proteinPeptides<3 kDain vitro60%NDUltrasonic pretreated enzymolisis increased ECA-inhibitory activities of the oat peptides[81]
Oat protein hydrolysatePeptidesNDin silico96.5%NDInhibition of ECA-I by aromatic, small acids with low lipophilicity and high electronic properties[82]
Oat protein hydrolysatePeptides<3 kDain vitro e in silico35 µg/mLNDCompetitive inhibitors of ECA[83]
Sweet sorghum grain Peptides fractions<1 kDain vitro31.6 µg/mLNDBinding of the C-terminal of Serine with the active sites of ECA[84]
Sorghum protein hydrolysateTripeptidesNDin vitro1.3 µg/mLNDCompetitive inhibitor of ECA[85]
Bread produced with addition of 6% rye-malt glutenPeptidesNDin vitro0.002 µM/mLNDECA binding at the N-terminal and proline or aromatic amino acids at the C-terminus[86]
Extruded and fermented milletPeptidesNDin vivoND14.6%Reduction in the indexes of RAAS[87]
Bread or sandwiches with pure millet grainsProteinNDClinicalND3% Inhibition of vasoconstrictors and induction of vasodilators[88]
BP: Blood Pressure; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; MW: Molecular weight; % IECA: Percent inhibition of ECA; Ala: Alanine; Arg: Arginine; Cys: Cysteine; Gln: Glutamine; Glu: Glutamic acid; Ile: Isoleucine; Leu: Leucine; Lys: Lysine; Phe: Phenylalanine; Pro: Proline; Ser: Serine; Thr: Threonine; Trp: Tryptophan; Tyr: Tyrosine; Val: Valine; NOS: Nitric oxide synthase; ND: Not determined.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

García-Castro, A.; Román-Gutiérrez, A.D.; Castañeda-Ovando, A.; Cariño-Cortés, R.; Acevedo-Sandoval, O.A.; López-Perea, P.; Guzmán-Ortiz, F.A. Cereals as a Source of Bioactive Compounds with Anti-Hypertensive Activity and Their Intake in Times of COVID-19. Foods 2022, 11, 3231. https://doi.org/10.3390/foods11203231

AMA Style

García-Castro A, Román-Gutiérrez AD, Castañeda-Ovando A, Cariño-Cortés R, Acevedo-Sandoval OA, López-Perea P, Guzmán-Ortiz FA. Cereals as a Source of Bioactive Compounds with Anti-Hypertensive Activity and Their Intake in Times of COVID-19. Foods. 2022; 11(20):3231. https://doi.org/10.3390/foods11203231

Chicago/Turabian Style

García-Castro, Abigail, Alma Delia Román-Gutiérrez, Araceli Castañeda-Ovando, Raquel Cariño-Cortés, Otilio Arturo Acevedo-Sandoval, Patricia López-Perea, and Fabiola Araceli Guzmán-Ortiz. 2022. "Cereals as a Source of Bioactive Compounds with Anti-Hypertensive Activity and Their Intake in Times of COVID-19" Foods 11, no. 20: 3231. https://doi.org/10.3390/foods11203231

APA Style

García-Castro, A., Román-Gutiérrez, A. D., Castañeda-Ovando, A., Cariño-Cortés, R., Acevedo-Sandoval, O. A., López-Perea, P., & Guzmán-Ortiz, F. A. (2022). Cereals as a Source of Bioactive Compounds with Anti-Hypertensive Activity and Their Intake in Times of COVID-19. Foods, 11(20), 3231. https://doi.org/10.3390/foods11203231

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop